1
|
Chhabra P, Tully DC, Mans J, Niendorf S, Barclay L, Cannon JL, Montmayeur AM, Pan CY, Page N, Williams R, Tutill H, Roy S, Celma C, Beard S, Mallory ML, Manouana GP, Velavan TP, Adegnika AA, Kremsner PG, Lindesmith LC, Hué S, Baric RS, Breuer J, Vinjé J. Emergence of Novel Norovirus GII.4 Variant. Emerg Infect Dis 2024; 30:163-167. [PMID: 38063078 PMCID: PMC10756382 DOI: 10.3201/eid3001.231003] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2023] Open
Abstract
We detected a novel GII.4 variant with an amino acid insertion at the start of epitope A in viral protein 1 of noroviruses from the United States, Gabon, South Africa, and the United Kingdom collected during 2017-2022. Early identification of GII.4 variants is crucial for assessing pandemic potential and informing vaccine development.
Collapse
Affiliation(s)
| | | | - Janet Mans
- Centers for Disease Control and Prevention, Atlanta, Georgia, USA (P. Chhabra, L. Barclay, J.L. Cannon, A.M. Montmayeur, J. Vinjé)
- London School of Hygiene & Tropical Medicine, London, UK (D.C. Tully, S. Hué)
- University of Pretoria, Pretoria, South Africa (J. Mans, N. Page)
- Robert Koch Institut, Berlin, Germany (S. Niendorf)
- California Department of Public Health, Richmond, California, USA (C.-Y. Pan)
- National Institute for Communicable Diseases, Sandringham, South Africa (N. Page)
- UCL Great Ormond Street Institute of Child Health, London (R. Williams, H. Tutill, S. Roy, J. Breuer)
- UK Health Security Agency, London (C. Celma, S. Beard)
- University of North Carolina, Chapel Hill, North Carolina, USA (M.L. Mallory, L.C. Lindesmith, R.S. Baric)
- Universitätsklinikum Tübingen, Tübingen, Germany (G.P. Manouana, T.P. Velavan, A.A. Adegnika)
- Centre de Recherches Médicales de Lambaréné, Lambarene, Gabon (G.P. Manouana, A.A. Adegnika, P.G. Kremsner)
- Vietnamese-German Center for Medical Research, Hanoi, Vietnam (T.P. Velavan)
- Duy Tan University, Da Nang, Vietnam (T.P. Velavan)
- German Center for Infection Research, Tübingen (A.A. Adegnika)
| | - Sandra Niendorf
- Centers for Disease Control and Prevention, Atlanta, Georgia, USA (P. Chhabra, L. Barclay, J.L. Cannon, A.M. Montmayeur, J. Vinjé)
- London School of Hygiene & Tropical Medicine, London, UK (D.C. Tully, S. Hué)
- University of Pretoria, Pretoria, South Africa (J. Mans, N. Page)
- Robert Koch Institut, Berlin, Germany (S. Niendorf)
- California Department of Public Health, Richmond, California, USA (C.-Y. Pan)
- National Institute for Communicable Diseases, Sandringham, South Africa (N. Page)
- UCL Great Ormond Street Institute of Child Health, London (R. Williams, H. Tutill, S. Roy, J. Breuer)
- UK Health Security Agency, London (C. Celma, S. Beard)
- University of North Carolina, Chapel Hill, North Carolina, USA (M.L. Mallory, L.C. Lindesmith, R.S. Baric)
- Universitätsklinikum Tübingen, Tübingen, Germany (G.P. Manouana, T.P. Velavan, A.A. Adegnika)
- Centre de Recherches Médicales de Lambaréné, Lambarene, Gabon (G.P. Manouana, A.A. Adegnika, P.G. Kremsner)
- Vietnamese-German Center for Medical Research, Hanoi, Vietnam (T.P. Velavan)
- Duy Tan University, Da Nang, Vietnam (T.P. Velavan)
- German Center for Infection Research, Tübingen (A.A. Adegnika)
| | - Leslie Barclay
- Centers for Disease Control and Prevention, Atlanta, Georgia, USA (P. Chhabra, L. Barclay, J.L. Cannon, A.M. Montmayeur, J. Vinjé)
- London School of Hygiene & Tropical Medicine, London, UK (D.C. Tully, S. Hué)
- University of Pretoria, Pretoria, South Africa (J. Mans, N. Page)
- Robert Koch Institut, Berlin, Germany (S. Niendorf)
- California Department of Public Health, Richmond, California, USA (C.-Y. Pan)
- National Institute for Communicable Diseases, Sandringham, South Africa (N. Page)
- UCL Great Ormond Street Institute of Child Health, London (R. Williams, H. Tutill, S. Roy, J. Breuer)
- UK Health Security Agency, London (C. Celma, S. Beard)
- University of North Carolina, Chapel Hill, North Carolina, USA (M.L. Mallory, L.C. Lindesmith, R.S. Baric)
- Universitätsklinikum Tübingen, Tübingen, Germany (G.P. Manouana, T.P. Velavan, A.A. Adegnika)
- Centre de Recherches Médicales de Lambaréné, Lambarene, Gabon (G.P. Manouana, A.A. Adegnika, P.G. Kremsner)
- Vietnamese-German Center for Medical Research, Hanoi, Vietnam (T.P. Velavan)
- Duy Tan University, Da Nang, Vietnam (T.P. Velavan)
- German Center for Infection Research, Tübingen (A.A. Adegnika)
| | - Jennifer L. Cannon
- Centers for Disease Control and Prevention, Atlanta, Georgia, USA (P. Chhabra, L. Barclay, J.L. Cannon, A.M. Montmayeur, J. Vinjé)
- London School of Hygiene & Tropical Medicine, London, UK (D.C. Tully, S. Hué)
- University of Pretoria, Pretoria, South Africa (J. Mans, N. Page)
- Robert Koch Institut, Berlin, Germany (S. Niendorf)
- California Department of Public Health, Richmond, California, USA (C.-Y. Pan)
- National Institute for Communicable Diseases, Sandringham, South Africa (N. Page)
- UCL Great Ormond Street Institute of Child Health, London (R. Williams, H. Tutill, S. Roy, J. Breuer)
- UK Health Security Agency, London (C. Celma, S. Beard)
- University of North Carolina, Chapel Hill, North Carolina, USA (M.L. Mallory, L.C. Lindesmith, R.S. Baric)
- Universitätsklinikum Tübingen, Tübingen, Germany (G.P. Manouana, T.P. Velavan, A.A. Adegnika)
- Centre de Recherches Médicales de Lambaréné, Lambarene, Gabon (G.P. Manouana, A.A. Adegnika, P.G. Kremsner)
- Vietnamese-German Center for Medical Research, Hanoi, Vietnam (T.P. Velavan)
- Duy Tan University, Da Nang, Vietnam (T.P. Velavan)
- German Center for Infection Research, Tübingen (A.A. Adegnika)
| | - Anna M. Montmayeur
- Centers for Disease Control and Prevention, Atlanta, Georgia, USA (P. Chhabra, L. Barclay, J.L. Cannon, A.M. Montmayeur, J. Vinjé)
- London School of Hygiene & Tropical Medicine, London, UK (D.C. Tully, S. Hué)
- University of Pretoria, Pretoria, South Africa (J. Mans, N. Page)
- Robert Koch Institut, Berlin, Germany (S. Niendorf)
- California Department of Public Health, Richmond, California, USA (C.-Y. Pan)
- National Institute for Communicable Diseases, Sandringham, South Africa (N. Page)
- UCL Great Ormond Street Institute of Child Health, London (R. Williams, H. Tutill, S. Roy, J. Breuer)
- UK Health Security Agency, London (C. Celma, S. Beard)
- University of North Carolina, Chapel Hill, North Carolina, USA (M.L. Mallory, L.C. Lindesmith, R.S. Baric)
- Universitätsklinikum Tübingen, Tübingen, Germany (G.P. Manouana, T.P. Velavan, A.A. Adegnika)
- Centre de Recherches Médicales de Lambaréné, Lambarene, Gabon (G.P. Manouana, A.A. Adegnika, P.G. Kremsner)
- Vietnamese-German Center for Medical Research, Hanoi, Vietnam (T.P. Velavan)
- Duy Tan University, Da Nang, Vietnam (T.P. Velavan)
- German Center for Infection Research, Tübingen (A.A. Adegnika)
| | - Chao-Yang Pan
- Centers for Disease Control and Prevention, Atlanta, Georgia, USA (P. Chhabra, L. Barclay, J.L. Cannon, A.M. Montmayeur, J. Vinjé)
- London School of Hygiene & Tropical Medicine, London, UK (D.C. Tully, S. Hué)
- University of Pretoria, Pretoria, South Africa (J. Mans, N. Page)
- Robert Koch Institut, Berlin, Germany (S. Niendorf)
- California Department of Public Health, Richmond, California, USA (C.-Y. Pan)
- National Institute for Communicable Diseases, Sandringham, South Africa (N. Page)
- UCL Great Ormond Street Institute of Child Health, London (R. Williams, H. Tutill, S. Roy, J. Breuer)
- UK Health Security Agency, London (C. Celma, S. Beard)
- University of North Carolina, Chapel Hill, North Carolina, USA (M.L. Mallory, L.C. Lindesmith, R.S. Baric)
- Universitätsklinikum Tübingen, Tübingen, Germany (G.P. Manouana, T.P. Velavan, A.A. Adegnika)
- Centre de Recherches Médicales de Lambaréné, Lambarene, Gabon (G.P. Manouana, A.A. Adegnika, P.G. Kremsner)
- Vietnamese-German Center for Medical Research, Hanoi, Vietnam (T.P. Velavan)
- Duy Tan University, Da Nang, Vietnam (T.P. Velavan)
- German Center for Infection Research, Tübingen (A.A. Adegnika)
| | - Nicola Page
- Centers for Disease Control and Prevention, Atlanta, Georgia, USA (P. Chhabra, L. Barclay, J.L. Cannon, A.M. Montmayeur, J. Vinjé)
- London School of Hygiene & Tropical Medicine, London, UK (D.C. Tully, S. Hué)
- University of Pretoria, Pretoria, South Africa (J. Mans, N. Page)
- Robert Koch Institut, Berlin, Germany (S. Niendorf)
- California Department of Public Health, Richmond, California, USA (C.-Y. Pan)
- National Institute for Communicable Diseases, Sandringham, South Africa (N. Page)
- UCL Great Ormond Street Institute of Child Health, London (R. Williams, H. Tutill, S. Roy, J. Breuer)
- UK Health Security Agency, London (C. Celma, S. Beard)
- University of North Carolina, Chapel Hill, North Carolina, USA (M.L. Mallory, L.C. Lindesmith, R.S. Baric)
- Universitätsklinikum Tübingen, Tübingen, Germany (G.P. Manouana, T.P. Velavan, A.A. Adegnika)
- Centre de Recherches Médicales de Lambaréné, Lambarene, Gabon (G.P. Manouana, A.A. Adegnika, P.G. Kremsner)
- Vietnamese-German Center for Medical Research, Hanoi, Vietnam (T.P. Velavan)
- Duy Tan University, Da Nang, Vietnam (T.P. Velavan)
- German Center for Infection Research, Tübingen (A.A. Adegnika)
| | - Rachel Williams
- Centers for Disease Control and Prevention, Atlanta, Georgia, USA (P. Chhabra, L. Barclay, J.L. Cannon, A.M. Montmayeur, J. Vinjé)
- London School of Hygiene & Tropical Medicine, London, UK (D.C. Tully, S. Hué)
- University of Pretoria, Pretoria, South Africa (J. Mans, N. Page)
- Robert Koch Institut, Berlin, Germany (S. Niendorf)
- California Department of Public Health, Richmond, California, USA (C.-Y. Pan)
- National Institute for Communicable Diseases, Sandringham, South Africa (N. Page)
- UCL Great Ormond Street Institute of Child Health, London (R. Williams, H. Tutill, S. Roy, J. Breuer)
- UK Health Security Agency, London (C. Celma, S. Beard)
- University of North Carolina, Chapel Hill, North Carolina, USA (M.L. Mallory, L.C. Lindesmith, R.S. Baric)
- Universitätsklinikum Tübingen, Tübingen, Germany (G.P. Manouana, T.P. Velavan, A.A. Adegnika)
- Centre de Recherches Médicales de Lambaréné, Lambarene, Gabon (G.P. Manouana, A.A. Adegnika, P.G. Kremsner)
- Vietnamese-German Center for Medical Research, Hanoi, Vietnam (T.P. Velavan)
- Duy Tan University, Da Nang, Vietnam (T.P. Velavan)
- German Center for Infection Research, Tübingen (A.A. Adegnika)
| | - Helena Tutill
- Centers for Disease Control and Prevention, Atlanta, Georgia, USA (P. Chhabra, L. Barclay, J.L. Cannon, A.M. Montmayeur, J. Vinjé)
- London School of Hygiene & Tropical Medicine, London, UK (D.C. Tully, S. Hué)
- University of Pretoria, Pretoria, South Africa (J. Mans, N. Page)
- Robert Koch Institut, Berlin, Germany (S. Niendorf)
- California Department of Public Health, Richmond, California, USA (C.-Y. Pan)
- National Institute for Communicable Diseases, Sandringham, South Africa (N. Page)
- UCL Great Ormond Street Institute of Child Health, London (R. Williams, H. Tutill, S. Roy, J. Breuer)
- UK Health Security Agency, London (C. Celma, S. Beard)
- University of North Carolina, Chapel Hill, North Carolina, USA (M.L. Mallory, L.C. Lindesmith, R.S. Baric)
- Universitätsklinikum Tübingen, Tübingen, Germany (G.P. Manouana, T.P. Velavan, A.A. Adegnika)
- Centre de Recherches Médicales de Lambaréné, Lambarene, Gabon (G.P. Manouana, A.A. Adegnika, P.G. Kremsner)
- Vietnamese-German Center for Medical Research, Hanoi, Vietnam (T.P. Velavan)
- Duy Tan University, Da Nang, Vietnam (T.P. Velavan)
- German Center for Infection Research, Tübingen (A.A. Adegnika)
| | - Sunando Roy
- Centers for Disease Control and Prevention, Atlanta, Georgia, USA (P. Chhabra, L. Barclay, J.L. Cannon, A.M. Montmayeur, J. Vinjé)
- London School of Hygiene & Tropical Medicine, London, UK (D.C. Tully, S. Hué)
- University of Pretoria, Pretoria, South Africa (J. Mans, N. Page)
- Robert Koch Institut, Berlin, Germany (S. Niendorf)
- California Department of Public Health, Richmond, California, USA (C.-Y. Pan)
- National Institute for Communicable Diseases, Sandringham, South Africa (N. Page)
- UCL Great Ormond Street Institute of Child Health, London (R. Williams, H. Tutill, S. Roy, J. Breuer)
- UK Health Security Agency, London (C. Celma, S. Beard)
- University of North Carolina, Chapel Hill, North Carolina, USA (M.L. Mallory, L.C. Lindesmith, R.S. Baric)
- Universitätsklinikum Tübingen, Tübingen, Germany (G.P. Manouana, T.P. Velavan, A.A. Adegnika)
- Centre de Recherches Médicales de Lambaréné, Lambarene, Gabon (G.P. Manouana, A.A. Adegnika, P.G. Kremsner)
- Vietnamese-German Center for Medical Research, Hanoi, Vietnam (T.P. Velavan)
- Duy Tan University, Da Nang, Vietnam (T.P. Velavan)
- German Center for Infection Research, Tübingen (A.A. Adegnika)
| | - Cristina Celma
- Centers for Disease Control and Prevention, Atlanta, Georgia, USA (P. Chhabra, L. Barclay, J.L. Cannon, A.M. Montmayeur, J. Vinjé)
- London School of Hygiene & Tropical Medicine, London, UK (D.C. Tully, S. Hué)
- University of Pretoria, Pretoria, South Africa (J. Mans, N. Page)
- Robert Koch Institut, Berlin, Germany (S. Niendorf)
- California Department of Public Health, Richmond, California, USA (C.-Y. Pan)
- National Institute for Communicable Diseases, Sandringham, South Africa (N. Page)
- UCL Great Ormond Street Institute of Child Health, London (R. Williams, H. Tutill, S. Roy, J. Breuer)
- UK Health Security Agency, London (C. Celma, S. Beard)
- University of North Carolina, Chapel Hill, North Carolina, USA (M.L. Mallory, L.C. Lindesmith, R.S. Baric)
- Universitätsklinikum Tübingen, Tübingen, Germany (G.P. Manouana, T.P. Velavan, A.A. Adegnika)
- Centre de Recherches Médicales de Lambaréné, Lambarene, Gabon (G.P. Manouana, A.A. Adegnika, P.G. Kremsner)
- Vietnamese-German Center for Medical Research, Hanoi, Vietnam (T.P. Velavan)
- Duy Tan University, Da Nang, Vietnam (T.P. Velavan)
- German Center for Infection Research, Tübingen (A.A. Adegnika)
| | - Stuart Beard
- Centers for Disease Control and Prevention, Atlanta, Georgia, USA (P. Chhabra, L. Barclay, J.L. Cannon, A.M. Montmayeur, J. Vinjé)
- London School of Hygiene & Tropical Medicine, London, UK (D.C. Tully, S. Hué)
- University of Pretoria, Pretoria, South Africa (J. Mans, N. Page)
- Robert Koch Institut, Berlin, Germany (S. Niendorf)
- California Department of Public Health, Richmond, California, USA (C.-Y. Pan)
- National Institute for Communicable Diseases, Sandringham, South Africa (N. Page)
- UCL Great Ormond Street Institute of Child Health, London (R. Williams, H. Tutill, S. Roy, J. Breuer)
- UK Health Security Agency, London (C. Celma, S. Beard)
- University of North Carolina, Chapel Hill, North Carolina, USA (M.L. Mallory, L.C. Lindesmith, R.S. Baric)
- Universitätsklinikum Tübingen, Tübingen, Germany (G.P. Manouana, T.P. Velavan, A.A. Adegnika)
- Centre de Recherches Médicales de Lambaréné, Lambarene, Gabon (G.P. Manouana, A.A. Adegnika, P.G. Kremsner)
- Vietnamese-German Center for Medical Research, Hanoi, Vietnam (T.P. Velavan)
- Duy Tan University, Da Nang, Vietnam (T.P. Velavan)
- German Center for Infection Research, Tübingen (A.A. Adegnika)
| | - Michael L. Mallory
- Centers for Disease Control and Prevention, Atlanta, Georgia, USA (P. Chhabra, L. Barclay, J.L. Cannon, A.M. Montmayeur, J. Vinjé)
- London School of Hygiene & Tropical Medicine, London, UK (D.C. Tully, S. Hué)
- University of Pretoria, Pretoria, South Africa (J. Mans, N. Page)
- Robert Koch Institut, Berlin, Germany (S. Niendorf)
- California Department of Public Health, Richmond, California, USA (C.-Y. Pan)
- National Institute for Communicable Diseases, Sandringham, South Africa (N. Page)
- UCL Great Ormond Street Institute of Child Health, London (R. Williams, H. Tutill, S. Roy, J. Breuer)
- UK Health Security Agency, London (C. Celma, S. Beard)
- University of North Carolina, Chapel Hill, North Carolina, USA (M.L. Mallory, L.C. Lindesmith, R.S. Baric)
- Universitätsklinikum Tübingen, Tübingen, Germany (G.P. Manouana, T.P. Velavan, A.A. Adegnika)
- Centre de Recherches Médicales de Lambaréné, Lambarene, Gabon (G.P. Manouana, A.A. Adegnika, P.G. Kremsner)
- Vietnamese-German Center for Medical Research, Hanoi, Vietnam (T.P. Velavan)
- Duy Tan University, Da Nang, Vietnam (T.P. Velavan)
- German Center for Infection Research, Tübingen (A.A. Adegnika)
| | - Gédéon Prince Manouana
- Centers for Disease Control and Prevention, Atlanta, Georgia, USA (P. Chhabra, L. Barclay, J.L. Cannon, A.M. Montmayeur, J. Vinjé)
- London School of Hygiene & Tropical Medicine, London, UK (D.C. Tully, S. Hué)
- University of Pretoria, Pretoria, South Africa (J. Mans, N. Page)
- Robert Koch Institut, Berlin, Germany (S. Niendorf)
- California Department of Public Health, Richmond, California, USA (C.-Y. Pan)
- National Institute for Communicable Diseases, Sandringham, South Africa (N. Page)
- UCL Great Ormond Street Institute of Child Health, London (R. Williams, H. Tutill, S. Roy, J. Breuer)
- UK Health Security Agency, London (C. Celma, S. Beard)
- University of North Carolina, Chapel Hill, North Carolina, USA (M.L. Mallory, L.C. Lindesmith, R.S. Baric)
- Universitätsklinikum Tübingen, Tübingen, Germany (G.P. Manouana, T.P. Velavan, A.A. Adegnika)
- Centre de Recherches Médicales de Lambaréné, Lambarene, Gabon (G.P. Manouana, A.A. Adegnika, P.G. Kremsner)
- Vietnamese-German Center for Medical Research, Hanoi, Vietnam (T.P. Velavan)
- Duy Tan University, Da Nang, Vietnam (T.P. Velavan)
- German Center for Infection Research, Tübingen (A.A. Adegnika)
| | - Thirumalaisamy P. Velavan
- Centers for Disease Control and Prevention, Atlanta, Georgia, USA (P. Chhabra, L. Barclay, J.L. Cannon, A.M. Montmayeur, J. Vinjé)
- London School of Hygiene & Tropical Medicine, London, UK (D.C. Tully, S. Hué)
- University of Pretoria, Pretoria, South Africa (J. Mans, N. Page)
- Robert Koch Institut, Berlin, Germany (S. Niendorf)
- California Department of Public Health, Richmond, California, USA (C.-Y. Pan)
- National Institute for Communicable Diseases, Sandringham, South Africa (N. Page)
- UCL Great Ormond Street Institute of Child Health, London (R. Williams, H. Tutill, S. Roy, J. Breuer)
- UK Health Security Agency, London (C. Celma, S. Beard)
- University of North Carolina, Chapel Hill, North Carolina, USA (M.L. Mallory, L.C. Lindesmith, R.S. Baric)
- Universitätsklinikum Tübingen, Tübingen, Germany (G.P. Manouana, T.P. Velavan, A.A. Adegnika)
- Centre de Recherches Médicales de Lambaréné, Lambarene, Gabon (G.P. Manouana, A.A. Adegnika, P.G. Kremsner)
- Vietnamese-German Center for Medical Research, Hanoi, Vietnam (T.P. Velavan)
- Duy Tan University, Da Nang, Vietnam (T.P. Velavan)
- German Center for Infection Research, Tübingen (A.A. Adegnika)
| | - Ayola Akim Adegnika
- Centers for Disease Control and Prevention, Atlanta, Georgia, USA (P. Chhabra, L. Barclay, J.L. Cannon, A.M. Montmayeur, J. Vinjé)
- London School of Hygiene & Tropical Medicine, London, UK (D.C. Tully, S. Hué)
- University of Pretoria, Pretoria, South Africa (J. Mans, N. Page)
- Robert Koch Institut, Berlin, Germany (S. Niendorf)
- California Department of Public Health, Richmond, California, USA (C.-Y. Pan)
- National Institute for Communicable Diseases, Sandringham, South Africa (N. Page)
- UCL Great Ormond Street Institute of Child Health, London (R. Williams, H. Tutill, S. Roy, J. Breuer)
- UK Health Security Agency, London (C. Celma, S. Beard)
- University of North Carolina, Chapel Hill, North Carolina, USA (M.L. Mallory, L.C. Lindesmith, R.S. Baric)
- Universitätsklinikum Tübingen, Tübingen, Germany (G.P. Manouana, T.P. Velavan, A.A. Adegnika)
- Centre de Recherches Médicales de Lambaréné, Lambarene, Gabon (G.P. Manouana, A.A. Adegnika, P.G. Kremsner)
- Vietnamese-German Center for Medical Research, Hanoi, Vietnam (T.P. Velavan)
- Duy Tan University, Da Nang, Vietnam (T.P. Velavan)
- German Center for Infection Research, Tübingen (A.A. Adegnika)
| | - Peter G. Kremsner
- Centers for Disease Control and Prevention, Atlanta, Georgia, USA (P. Chhabra, L. Barclay, J.L. Cannon, A.M. Montmayeur, J. Vinjé)
- London School of Hygiene & Tropical Medicine, London, UK (D.C. Tully, S. Hué)
- University of Pretoria, Pretoria, South Africa (J. Mans, N. Page)
- Robert Koch Institut, Berlin, Germany (S. Niendorf)
- California Department of Public Health, Richmond, California, USA (C.-Y. Pan)
- National Institute for Communicable Diseases, Sandringham, South Africa (N. Page)
- UCL Great Ormond Street Institute of Child Health, London (R. Williams, H. Tutill, S. Roy, J. Breuer)
- UK Health Security Agency, London (C. Celma, S. Beard)
- University of North Carolina, Chapel Hill, North Carolina, USA (M.L. Mallory, L.C. Lindesmith, R.S. Baric)
- Universitätsklinikum Tübingen, Tübingen, Germany (G.P. Manouana, T.P. Velavan, A.A. Adegnika)
- Centre de Recherches Médicales de Lambaréné, Lambarene, Gabon (G.P. Manouana, A.A. Adegnika, P.G. Kremsner)
- Vietnamese-German Center for Medical Research, Hanoi, Vietnam (T.P. Velavan)
- Duy Tan University, Da Nang, Vietnam (T.P. Velavan)
- German Center for Infection Research, Tübingen (A.A. Adegnika)
| | - Lisa C. Lindesmith
- Centers for Disease Control and Prevention, Atlanta, Georgia, USA (P. Chhabra, L. Barclay, J.L. Cannon, A.M. Montmayeur, J. Vinjé)
- London School of Hygiene & Tropical Medicine, London, UK (D.C. Tully, S. Hué)
- University of Pretoria, Pretoria, South Africa (J. Mans, N. Page)
- Robert Koch Institut, Berlin, Germany (S. Niendorf)
- California Department of Public Health, Richmond, California, USA (C.-Y. Pan)
- National Institute for Communicable Diseases, Sandringham, South Africa (N. Page)
- UCL Great Ormond Street Institute of Child Health, London (R. Williams, H. Tutill, S. Roy, J. Breuer)
- UK Health Security Agency, London (C. Celma, S. Beard)
- University of North Carolina, Chapel Hill, North Carolina, USA (M.L. Mallory, L.C. Lindesmith, R.S. Baric)
- Universitätsklinikum Tübingen, Tübingen, Germany (G.P. Manouana, T.P. Velavan, A.A. Adegnika)
- Centre de Recherches Médicales de Lambaréné, Lambarene, Gabon (G.P. Manouana, A.A. Adegnika, P.G. Kremsner)
- Vietnamese-German Center for Medical Research, Hanoi, Vietnam (T.P. Velavan)
- Duy Tan University, Da Nang, Vietnam (T.P. Velavan)
- German Center for Infection Research, Tübingen (A.A. Adegnika)
| | - Stéphane Hué
- Centers for Disease Control and Prevention, Atlanta, Georgia, USA (P. Chhabra, L. Barclay, J.L. Cannon, A.M. Montmayeur, J. Vinjé)
- London School of Hygiene & Tropical Medicine, London, UK (D.C. Tully, S. Hué)
- University of Pretoria, Pretoria, South Africa (J. Mans, N. Page)
- Robert Koch Institut, Berlin, Germany (S. Niendorf)
- California Department of Public Health, Richmond, California, USA (C.-Y. Pan)
- National Institute for Communicable Diseases, Sandringham, South Africa (N. Page)
- UCL Great Ormond Street Institute of Child Health, London (R. Williams, H. Tutill, S. Roy, J. Breuer)
- UK Health Security Agency, London (C. Celma, S. Beard)
- University of North Carolina, Chapel Hill, North Carolina, USA (M.L. Mallory, L.C. Lindesmith, R.S. Baric)
- Universitätsklinikum Tübingen, Tübingen, Germany (G.P. Manouana, T.P. Velavan, A.A. Adegnika)
- Centre de Recherches Médicales de Lambaréné, Lambarene, Gabon (G.P. Manouana, A.A. Adegnika, P.G. Kremsner)
- Vietnamese-German Center for Medical Research, Hanoi, Vietnam (T.P. Velavan)
- Duy Tan University, Da Nang, Vietnam (T.P. Velavan)
- German Center for Infection Research, Tübingen (A.A. Adegnika)
| | - Ralph S. Baric
- Centers for Disease Control and Prevention, Atlanta, Georgia, USA (P. Chhabra, L. Barclay, J.L. Cannon, A.M. Montmayeur, J. Vinjé)
- London School of Hygiene & Tropical Medicine, London, UK (D.C. Tully, S. Hué)
- University of Pretoria, Pretoria, South Africa (J. Mans, N. Page)
- Robert Koch Institut, Berlin, Germany (S. Niendorf)
- California Department of Public Health, Richmond, California, USA (C.-Y. Pan)
- National Institute for Communicable Diseases, Sandringham, South Africa (N. Page)
- UCL Great Ormond Street Institute of Child Health, London (R. Williams, H. Tutill, S. Roy, J. Breuer)
- UK Health Security Agency, London (C. Celma, S. Beard)
- University of North Carolina, Chapel Hill, North Carolina, USA (M.L. Mallory, L.C. Lindesmith, R.S. Baric)
- Universitätsklinikum Tübingen, Tübingen, Germany (G.P. Manouana, T.P. Velavan, A.A. Adegnika)
- Centre de Recherches Médicales de Lambaréné, Lambarene, Gabon (G.P. Manouana, A.A. Adegnika, P.G. Kremsner)
- Vietnamese-German Center for Medical Research, Hanoi, Vietnam (T.P. Velavan)
- Duy Tan University, Da Nang, Vietnam (T.P. Velavan)
- German Center for Infection Research, Tübingen (A.A. Adegnika)
| | - Judith Breuer
- Centers for Disease Control and Prevention, Atlanta, Georgia, USA (P. Chhabra, L. Barclay, J.L. Cannon, A.M. Montmayeur, J. Vinjé)
- London School of Hygiene & Tropical Medicine, London, UK (D.C. Tully, S. Hué)
- University of Pretoria, Pretoria, South Africa (J. Mans, N. Page)
- Robert Koch Institut, Berlin, Germany (S. Niendorf)
- California Department of Public Health, Richmond, California, USA (C.-Y. Pan)
- National Institute for Communicable Diseases, Sandringham, South Africa (N. Page)
- UCL Great Ormond Street Institute of Child Health, London (R. Williams, H. Tutill, S. Roy, J. Breuer)
- UK Health Security Agency, London (C. Celma, S. Beard)
- University of North Carolina, Chapel Hill, North Carolina, USA (M.L. Mallory, L.C. Lindesmith, R.S. Baric)
- Universitätsklinikum Tübingen, Tübingen, Germany (G.P. Manouana, T.P. Velavan, A.A. Adegnika)
- Centre de Recherches Médicales de Lambaréné, Lambarene, Gabon (G.P. Manouana, A.A. Adegnika, P.G. Kremsner)
- Vietnamese-German Center for Medical Research, Hanoi, Vietnam (T.P. Velavan)
- Duy Tan University, Da Nang, Vietnam (T.P. Velavan)
- German Center for Infection Research, Tübingen (A.A. Adegnika)
| | - Jan Vinjé
- Centers for Disease Control and Prevention, Atlanta, Georgia, USA (P. Chhabra, L. Barclay, J.L. Cannon, A.M. Montmayeur, J. Vinjé)
- London School of Hygiene & Tropical Medicine, London, UK (D.C. Tully, S. Hué)
- University of Pretoria, Pretoria, South Africa (J. Mans, N. Page)
- Robert Koch Institut, Berlin, Germany (S. Niendorf)
- California Department of Public Health, Richmond, California, USA (C.-Y. Pan)
- National Institute for Communicable Diseases, Sandringham, South Africa (N. Page)
- UCL Great Ormond Street Institute of Child Health, London (R. Williams, H. Tutill, S. Roy, J. Breuer)
- UK Health Security Agency, London (C. Celma, S. Beard)
- University of North Carolina, Chapel Hill, North Carolina, USA (M.L. Mallory, L.C. Lindesmith, R.S. Baric)
- Universitätsklinikum Tübingen, Tübingen, Germany (G.P. Manouana, T.P. Velavan, A.A. Adegnika)
- Centre de Recherches Médicales de Lambaréné, Lambarene, Gabon (G.P. Manouana, A.A. Adegnika, P.G. Kremsner)
- Vietnamese-German Center for Medical Research, Hanoi, Vietnam (T.P. Velavan)
- Duy Tan University, Da Nang, Vietnam (T.P. Velavan)
- German Center for Infection Research, Tübingen (A.A. Adegnika)
| |
Collapse
|
2
|
Pan CY, Bai WH, Sun MM, Wei SH, Zhou HF. [Optic atrophy in a patient with axonal Charcot-Marie-Tooth disease 2A2A due to MFN2 gene mutations]. Zhonghua Yan Ke Za Zhi 2023; 59:408-410. [PMID: 37151011 DOI: 10.3760/cma.j.cn112142-20220611-00289] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Subscribe] [Scholar Register] [Indexed: 05/09/2023]
Abstract
A 27-year-old male patient had progressive vision loss in both eyes, which was mainly manifested by impaired ganglion cells in the macular area, accompanied by systemic muscle atrophy in limbs. A complete mitochondrial exon gene detection was performed. The final diagnosis was bilateral optic atrophy and axonal Charcot-Marie-Tooth disease 2A2A caused by mutations of the MFN2 gene. There has been no effective treatment. Applications of nutrients to restore the mitochondrial function may alleviate the clinical symptoms.
Collapse
Affiliation(s)
- C Y Pan
- Ophthalmology Division of Chinese PLA General Hospital, Beijing 100853, China
| | - W H Bai
- Ophthalmology Division of Chinese PLA General Hospital, Beijing 100853, China
| | - M M Sun
- Ophthalmology Division of Chinese PLA General Hospital, Beijing 100853, China
| | - S H Wei
- Ophthalmology Division of Chinese PLA General Hospital, Beijing 100853, China
| | - H F Zhou
- Ophthalmology Division of Chinese PLA General Hospital, Beijing 100853, China
| |
Collapse
|
3
|
Servellita V, Sotomayor Gonzalez A, Lamson DM, Foresythe A, Huh HJ, Bazinet AL, Bergman NH, Bull RL, Garcia KY, Goodrich JS, Lovett SP, Parker K, Radune D, Hatada A, Pan CY, Rizzo K, Bertumen JB, Morales C, Oluniyi PE, Nguyen J, Tan J, Stryke D, Jaber R, Leslie MT, Lyons Z, Hedman HD, Parashar U, Sullivan M, Wroblewski K, Oberste MS, Tate JE, Baker JM, Sugerman D, Potts C, Lu X, Chhabra P, Ingram LA, Shiau H, Britt W, Gutierrez Sanchez LH, Ciric C, Rostad CA, Vinjé J, Kirking HL, Wadford DA, Raborn RT, St George K, Chiu CY. Adeno-associated virus type 2 in US children with acute severe hepatitis. Nature 2023; 617:574-580. [PMID: 36996871 PMCID: PMC10170441 DOI: 10.1038/s41586-023-05949-1] [Citation(s) in RCA: 43] [Impact Index Per Article: 43.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/11/2022] [Accepted: 03/10/2023] [Indexed: 04/01/2023]
Abstract
As of August 2022, clusters of acute severe hepatitis of unknown aetiology in children have been reported from 35 countries, including the USA1,2. Previous studies have found human adenoviruses (HAdVs) in the blood from patients in Europe and the USA3-7, although it is unclear whether this virus is causative. Here we used PCR testing, viral enrichment-based sequencing and agnostic metagenomic sequencing to analyse samples from 16 HAdV-positive cases from 1 October 2021 to 22 May 2022, in parallel with 113 controls. In blood from 14 cases, adeno-associated virus type 2 (AAV2) sequences were detected in 93% (13 of 14), compared to 4 (3.5%) of 113 controls (P < 0.001) and to 0 of 30 patients with hepatitis of defined aetiology (P < 0.001). In controls, HAdV type 41 was detected in blood from 9 (39.1%) of the 23 patients with acute gastroenteritis (without hepatitis), including 8 of 9 patients with positive stool HAdV testing, but co-infection with AAV2 was observed in only 3 (13.0%) of these 23 patients versus 93% of cases (P < 0.001). Co-infections by Epstein-Barr virus, human herpesvirus 6 and/or enterovirus A71 were also detected in 12 (85.7%) of 14 cases, with higher herpesvirus detection in cases versus controls (P < 0.001). Our findings suggest that the severity of the disease is related to co-infections involving AAV2 and one or more helper viruses.
Collapse
Affiliation(s)
- Venice Servellita
- Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, USA
| | | | - Daryl M Lamson
- Wadsworth Center, New York State Department of Health, David Axelrod Institute, Albany, NY, USA
| | - Abiodun Foresythe
- Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, USA
| | - Hee Jae Huh
- Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, USA
- Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
| | - Adam L Bazinet
- National Biodefense Analysis and Countermeasures Center (NBACC), Frederick, MD, USA
| | - Nicholas H Bergman
- National Biodefense Analysis and Countermeasures Center (NBACC), Frederick, MD, USA
| | - Robert L Bull
- Federal Bureau of Investigation Laboratory Division/Scientific Response and Analysis Unit, Quantico, VA, USA
| | - Karla Y Garcia
- National Biodefense Analysis and Countermeasures Center (NBACC), Frederick, MD, USA
| | - Jennifer S Goodrich
- National Biodefense Analysis and Countermeasures Center (NBACC), Frederick, MD, USA
| | - Sean P Lovett
- National Biodefense Analysis and Countermeasures Center (NBACC), Frederick, MD, USA
| | - Kisha Parker
- National Biodefense Analysis and Countermeasures Center (NBACC), Frederick, MD, USA
| | - Diana Radune
- National Biodefense Analysis and Countermeasures Center (NBACC), Frederick, MD, USA
| | - April Hatada
- California Department of Public Health, Richmond, CA, USA
| | - Chao-Yang Pan
- California Department of Public Health, Richmond, CA, USA
| | - Kyle Rizzo
- California Department of Public Health, Richmond, CA, USA
| | - J Bradford Bertumen
- California Department of Public Health, Richmond, CA, USA
- Centers for Disease Control and Prevention, Atlanta, CA, USA
| | | | - Paul E Oluniyi
- Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, USA
| | - Jenny Nguyen
- Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, USA
| | - Jessica Tan
- Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, USA
| | - Doug Stryke
- Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, USA
| | - Rayah Jaber
- Florida Department of Health, Tallahassee, FL, USA
| | | | - Zin Lyons
- North Carolina Department of Health and Human Services, Raleigh, NC, USA
| | - Hayden D Hedman
- Centers for Disease Control and Prevention, Atlanta, CA, USA
- South Dakota Department of Health, Pierre, SD, USA
| | - Umesh Parashar
- Centers for Disease Control and Prevention, Atlanta, CA, USA
| | - Maureen Sullivan
- Association for Public Health Laboratories, Silver Spring, MD, USA
| | - Kelly Wroblewski
- Association for Public Health Laboratories, Silver Spring, MD, USA
| | | | | | - Julia M Baker
- Centers for Disease Control and Prevention, Atlanta, CA, USA
| | - David Sugerman
- Centers for Disease Control and Prevention, Atlanta, CA, USA
| | - Caelin Potts
- Centers for Disease Control and Prevention, Atlanta, CA, USA
| | - Xiaoyan Lu
- Centers for Disease Control and Prevention, Atlanta, CA, USA
| | - Preeti Chhabra
- Centers for Disease Control and Prevention, Atlanta, CA, USA
| | | | - Henry Shiau
- University of Alabama at Birmingham, Birmingham, AL, USA
| | - William Britt
- University of Alabama at Birmingham, Birmingham, AL, USA
| | | | - Caroline Ciric
- Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, GA, USA
| | - Christina A Rostad
- Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, GA, USA
| | - Jan Vinjé
- Centers for Disease Control and Prevention, Atlanta, CA, USA
| | | | | | - R Taylor Raborn
- National Biodefense Analysis and Countermeasures Center (NBACC), Frederick, MD, USA
| | - Kirsten St George
- Wadsworth Center, New York State Department of Health, David Axelrod Institute, Albany, NY, USA
- Department of Biomedical Science, University at Albany, SUNY, Albany, NY, USA
| | - Charles Y Chiu
- Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, USA.
- Department of Medicine, Division of Infectious Diseases, University of California, San Francisco, San Francisco, CA, USA.
- Chan-Zuckerberg Biohub, San Francisco, CA, USA.
| |
Collapse
|
4
|
Osborn B, Pan CY, Hatada A, Hatfield J, Wagner J, Oakeson K, Montmayeur A, Morales C, Vinjé J. Cluster of Norovirus Genogroup IX Outbreaks in Long-Term Care Facilities, Utah, USA, 2021. Emerg Infect Dis 2022; 28:2312-2315. [PMID: 36286223 PMCID: PMC9622255 DOI: 10.3201/eid2811.220842] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
Abstract
We report 5 clustered acute gastroenteritis outbreaks in long-term care facilities in Utah, USA, that were linked to healthcare employees working at multiple facilities. Four outbreaks were caused by norovirus genotype GIX. We recommend continued norovirus surveillance and genotyping to determine contributions of this genotype to norovirus outbreaks.
Collapse
|
5
|
Cannon JL, Bonifacio J, Bucardo F, Buesa J, Bruggink L, Chan MCW, Fumian TM, Giri S, Gonzalez MD, Hewitt J, Lin JH, Mans J, Muñoz C, Pan CY, Pang XL, Pietsch C, Rahman M, Sakon N, Selvarangan R, Browne H, Barclay L, Vinjé J. Global Trends in Norovirus Genotype Distribution among Children with Acute Gastroenteritis. Emerg Infect Dis 2021; 27:1438-1445. [PMID: 33900173 PMCID: PMC8084493 DOI: 10.3201/eid2705.204756] [Citation(s) in RCA: 68] [Impact Index Per Article: 22.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022] Open
Abstract
Noroviruses are a leading cause of acute gastroenteritis (AGE) among adults and children worldwide. NoroSurv is a global network for norovirus strain surveillance among children <5 years of age with AGE. Participants in 16 countries across 6 continents used standardized protocols for dual typing (genotype and polymerase type) and uploaded 1,325 dual-typed sequences to the NoroSurv web portal during 2016-2020. More than 50% of submitted sequences were GII.4 Sydney[P16] or GII.4 Sydney[P31] strains. Other common strains included GII.2[P16], GII.3[P12], GII.6[P7], and GI.3[P3] viruses. In total, 22 genotypes and 36 dual types, including GII.3 and GII.20 viruses with rarely reported polymerase types, were detected, reflecting high strain diversity. Surveillance data captured in NoroSurv enables the monitoring of trends in norovirus strains associated childhood AGE throughout the world on a near real-time basis.
Collapse
|
6
|
Ng DL, Granados AC, Santos YA, Servellita V, Goldgof GM, Meydan C, Sotomayor-Gonzalez A, Levine AG, Balcerek J, Han LM, Akagi N, Truong K, Neumann NM, Nguyen DN, Bapat SP, Cheng J, Martin CSS, Federman S, Foox J, Gopez A, Li T, Chan R, Chu CS, Wabl CA, Gliwa AS, Reyes K, Pan CY, Guevara H, Wadford D, Miller S, Mason CE, Chiu CY. A diagnostic host response biosignature for COVID-19 from RNA profiling of nasal swabs and blood. Sci Adv 2021; 7:eabe5984. [PMID: 33536218 PMCID: PMC7857687 DOI: 10.1126/sciadv.abe5984] [Citation(s) in RCA: 59] [Impact Index Per Article: 19.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/01/2020] [Accepted: 12/15/2020] [Indexed: 05/05/2023]
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease-19 (COVID-19), has emerged as the cause of a global pandemic. We used RNA sequencing to analyze 286 nasopharyngeal (NP) swab and 53 whole-blood (WB) samples from 333 patients with COVID-19 and controls. Overall, a muted immune response was observed in COVID-19 relative to other infections (influenza, other seasonal coronaviruses, and bacterial sepsis), with paradoxical down-regulation of several key differentially expressed genes. Hospitalized patients and outpatients exhibited up-regulation of interferon-associated pathways, although heightened and more robust inflammatory responses were observed in hospitalized patients with more clinically severe illness. Two-layer machine learning-based host classifiers consisting of complete (>1000 genes), medium (<100), and small (<20) gene biomarker panels identified COVID-19 disease with 85.1-86.5% accuracy when benchmarked using an independent test set. SARS-CoV-2 infection has a distinct biosignature that differs between NP swabs and WB and can be leveraged for COVID-19 diagnosis.
Collapse
Affiliation(s)
- Dianna L Ng
- Department of Pathology, University of California, San Francisco, San Francisco, CA, USA
- Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, USA
| | - Andrea C Granados
- Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, USA
- UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, CA, USA
| | - Yale A Santos
- Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, USA
- UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, CA, USA
| | - Venice Servellita
- Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, USA
- UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, CA, USA
| | - Gregory M Goldgof
- Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, USA
| | - Cem Meydan
- Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA
- The HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA
- WorldQuant Initiative for Quantitative Prediction, Weill Cornell Medicine, New York, NY, USA
| | - Alicia Sotomayor-Gonzalez
- Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, USA
- UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, CA, USA
| | - Andrew G Levine
- Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, USA
| | - Joanna Balcerek
- Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, USA
| | - Lucy M Han
- Department of Pathology, University of California, San Francisco, San Francisco, CA, USA
| | - Naomi Akagi
- Department of Pathology, University of California, San Francisco, San Francisco, CA, USA
| | - Kent Truong
- Department of Pathology, University of California, San Francisco, San Francisco, CA, USA
| | - Neil M Neumann
- Department of Pathology, University of California, San Francisco, San Francisco, CA, USA
| | - David N Nguyen
- Diabetes Center, University of California, San Francisco, San Francisco, CA, USA
| | - Sagar P Bapat
- Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, USA
- Diabetes Center, University of California, San Francisco, San Francisco, CA, USA
- Department of Medicine, Division of Infectious Diseases, University of California, San Francisco, San Francisco, CA, USA
| | - Jing Cheng
- Department of Preventive and Restorative Dental Sciences, University of California, San Francisco, San Francisco, CA, USA
- Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA
| | - Claudia Sanchez-San Martin
- Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, USA
- UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, CA, USA
| | - Scot Federman
- Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, USA
- UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, CA, USA
| | - Jonathan Foox
- Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA
- The HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA
- WorldQuant Initiative for Quantitative Prediction, Weill Cornell Medicine, New York, NY, USA
| | - Allan Gopez
- Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, USA
- UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, CA, USA
| | - Tony Li
- Department of Medicine, Division of Hematology and Oncology, University of California, San Francisco, San Francisco, CA, USA
| | - Ray Chan
- Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, USA
| | - Cynthia S Chu
- Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, USA
| | - Chiara A Wabl
- Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, USA
- UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, CA, USA
| | - Amelia S Gliwa
- Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, USA
- UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, CA, USA
| | - Kevin Reyes
- Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, USA
- UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, CA, USA
| | - Chao-Yang Pan
- Viral and Rickettsial Disease Laboratory, California Department of Health, Richmond, CA, USA
| | - Hugo Guevara
- Viral and Rickettsial Disease Laboratory, California Department of Health, Richmond, CA, USA
| | - Debra Wadford
- Viral and Rickettsial Disease Laboratory, California Department of Health, Richmond, CA, USA
| | - Steve Miller
- Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, USA
- UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, CA, USA
| | - Christopher E Mason
- Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA
- The HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA
- New York Genome Center, New York, NY, USA
- Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, USA
| | - Charles Y Chiu
- Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, USA.
- UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, CA, USA
- Department of Medicine, Division of Infectious Diseases, University of California, San Francisco, San Francisco, CA, USA
| |
Collapse
|
7
|
Chhabra P, Browne H, Huynh T, Diez-Valcarce M, Barclay L, Kosek MN, Ahmed T, Lopez MR, Pan CY, Vinjé J. Single-step RT-PCR assay for dual genotyping of GI and GII norovirus strains. J Clin Virol 2020; 134:104689. [PMID: 33260046 PMCID: PMC7816162 DOI: 10.1016/j.jcv.2020.104689] [Citation(s) in RCA: 25] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/05/2020] [Revised: 10/21/2020] [Accepted: 11/06/2020] [Indexed: 01/21/2023]
Abstract
BACKGROUND Noroviruses are the major cause of acute gastroenteritis (AGE) in people of all ages globally. Standardized genotyping is key for outbreak investigations and surveillance networks. OBJECTIVE Here we describe the validation of a one-step conventional RT-PCR assay for sequence-based dual typing of GI and GII noroviruses. This polymerase (P) and capsid (C) dual typing assay uses a combination of previously published oligonucleotide primers amplifying a genomic region spanning the 3'-end of ORF1 and 5'end of ORF2 resulting in a 579 bp product for GI and 570 bp product for GII viruses. RESULTS The limit of detection of the assay ranged from 5 to 50 copies of viral RNA per reaction for GI and GII. To validate the assay, we tested 2,663 noroviruspositive stool samples from outbreaks and sporadic cases of AGE in Bangladesh, Guatemala, Peru, and USA collected between 2010-2019, of which 2,392 (90 %) were genotyped successfully. Most of the known genotypes infecting humans (GI (n = 9) and GII (n = 23)) and P types (GI (n = 15), GII, (n = 20)) could be detected. The remaining 270 samples had low viral load (Ct > 30) by real-time RT-PCR. A panel of 166 samples positive for other enteric viruses (rotavirus, astrovirus, sapovirus, adenovirus type 40/41) tested negative. CONCLUSION The use of broadly reactive genotyping assays greatly strengthens exchange of standardized genotype data globally to monitor trends in genotype diversity which is important for both the development of vaccines and to measure their impact.
Collapse
Affiliation(s)
- Preeti Chhabra
- Viral Gastroenteritis Branch, Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
| | - Hannah Browne
- National Foundation for the Centers for Disease Control and Prevention Inc., Atlanta, GA, USA
| | - Thalia Huynh
- California Department of Public Health, Richmond, CA, USA
| | | | - Leslie Barclay
- Viral Gastroenteritis Branch, Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
| | - Margaret N Kosek
- University of Virginia Division of Infectious Diseases and International Health, Charlottesville, VA, USA
| | - Tahmeed Ahmed
- International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh
| | | | - Chao-Yang Pan
- California Department of Public Health, Richmond, CA, USA
| | - Jan Vinjé
- Viral Gastroenteritis Branch, Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
| |
Collapse
|
8
|
Deng X, Gu W, Federman S, du Plessis L, Pybus OG, Faria NR, Wang C, Yu G, Bushnell B, Pan CY, Guevara H, Sotomayor-Gonzalez A, Zorn K, Gopez A, Servellita V, Hsu E, Miller S, Bedford T, Greninger AL, Roychoudhury P, Starita LM, Famulare M, Chu HY, Shendure J, Jerome KR, Anderson C, Gangavarapu K, Zeller M, Spencer E, Andersen KG, MacCannell D, Paden CR, Li Y, Zhang J, Tong S, Armstrong G, Morrow S, Willis M, Matyas BT, Mase S, Kasirye O, Park M, Masinde G, Chan C, Yu AT, Chai SJ, Villarino E, Bonin B, Wadford DA, Chiu CY. Genomic surveillance reveals multiple introductions of SARS-CoV-2 into Northern California. Science 2020; 369:582-587. [PMID: 32513865 PMCID: PMC7286545 DOI: 10.1126/science.abb9263] [Citation(s) in RCA: 196] [Impact Index Per Article: 49.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/27/2020] [Accepted: 06/03/2020] [Indexed: 12/30/2022]
Abstract
The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread globally, with >365,000 cases in California as of 17 July 2020. We investigated the genomic epidemiology of SARS-CoV-2 in Northern California from late January to mid-March 2020, using samples from 36 patients spanning nine counties and the Grand Princess cruise ship. Phylogenetic analyses revealed the cryptic introduction of at least seven different SARS-CoV-2 lineages into California, including epidemic WA1 strains associated with Washington state, with lack of a predominant lineage and limited transmission among communities. Lineages associated with outbreak clusters in two counties were defined by a single base substitution in the viral genome. These findings support contact tracing, social distancing, and travel restrictions to contain the spread of SARS-CoV-2 in California and other states.
Collapse
Affiliation(s)
- Xianding Deng
- Department of Laboratory Medicine, University of California, San Francisco, CA, USA
- UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, CA, USA
| | - Wei Gu
- Department of Laboratory Medicine, University of California, San Francisco, CA, USA
- UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, CA, USA
| | - Scot Federman
- Department of Laboratory Medicine, University of California, San Francisco, CA, USA
- UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, CA, USA
| | | | - Oliver G Pybus
- Department of Zoology, University of Oxford, Oxford, UK
- Department of Pathobiology and Population Sciences, Royal Veterinary College, London, UK
| | - Nuno R Faria
- Department of Zoology, University of Oxford, Oxford, UK
- MRC Centre for Global Infectious Disease Analysis, J-IDEA, Imperial College London, London, UK
| | - Candace Wang
- Department of Laboratory Medicine, University of California, San Francisco, CA, USA
- UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, CA, USA
| | - Guixia Yu
- Department of Laboratory Medicine, University of California, San Francisco, CA, USA
- UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, CA, USA
| | - Brian Bushnell
- Lawrence Berkeley National Laboratory, Berkeley, CA, USA
| | - Chao-Yang Pan
- California Department of Public Health, Richmond, CA, USA
| | - Hugo Guevara
- California Department of Public Health, Richmond, CA, USA
| | - Alicia Sotomayor-Gonzalez
- Department of Laboratory Medicine, University of California, San Francisco, CA, USA
- UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, CA, USA
| | - Kelsey Zorn
- Department of Biochemistry and Biophysics, University of California, San Francisco, CA, USA
| | - Allan Gopez
- Department of Laboratory Medicine, University of California, San Francisco, CA, USA
| | - Venice Servellita
- Department of Laboratory Medicine, University of California, San Francisco, CA, USA
| | - Elaine Hsu
- Department of Laboratory Medicine, University of California, San Francisco, CA, USA
| | - Steve Miller
- Department of Laboratory Medicine, University of California, San Francisco, CA, USA
| | - Trevor Bedford
- Fred Hutchinson Cancer Research Center, Seattle, WA, USA
- Brotman Baty Institute for Precision Medicine, Seattle, WA, USA
| | - Alexander L Greninger
- Fred Hutchinson Cancer Research Center, Seattle, WA, USA
- Department of Laboratory Medicine, University of Washington, Seattle, WA, USA
| | - Pavitra Roychoudhury
- Fred Hutchinson Cancer Research Center, Seattle, WA, USA
- Department of Laboratory Medicine, University of Washington, Seattle, WA, USA
| | - Lea M Starita
- Brotman Baty Institute for Precision Medicine, Seattle, WA, USA
- Department of Genome Sciences, University of Washington, Seattle, WA, USA
| | | | - Helen Y Chu
- Brotman Baty Institute for Precision Medicine, Seattle, WA, USA
- Department of Medicine, University of Washington, Seattle, WA, USA
| | - Jay Shendure
- Brotman Baty Institute for Precision Medicine, Seattle, WA, USA
- Department of Laboratory Medicine, University of Washington, Seattle, WA, USA
- Howard Hughes Medical Institute, University of Washington, Seattle, WA, USA
| | - Keith R Jerome
- Fred Hutchinson Cancer Research Center, Seattle, WA, USA
- Department of Laboratory Medicine, University of Washington, Seattle, WA, USA
| | - Catie Anderson
- Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA
| | - Karthik Gangavarapu
- Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA
| | - Mark Zeller
- Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA
| | - Emily Spencer
- Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA
| | - Kristian G Andersen
- Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA
| | | | - Clinton R Paden
- U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA
| | - Yan Li
- U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA
| | - Jing Zhang
- U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA
| | - Suxiang Tong
- U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA
| | | | - Scott Morrow
- San Mateo County Department of Public Health, San Mateo, CA, USA
| | - Matthew Willis
- Marin County Division of Public Health, San Rafael, CA, USA
| | - Bela T Matyas
- Solano County Department of Public Health, Fairfield, CA, USA
| | - Sundari Mase
- Sonoma County Department of Public Health, Santa Rosa, CA, USA
| | - Olivia Kasirye
- Sacramento County Division of Public Health, Sacramento, CA, USA
| | - Maggie Park
- San Joaquin County Department of Public Health, Stockton, CA, USA
| | - Godfred Masinde
- San Francisco County Department of Public Health, San Francisco, CA, USA
| | - Curtis Chan
- San Francisco County Department of Public Health, San Francisco, CA, USA
| | - Alexander T Yu
- California Department of Public Health, Richmond, CA, USA
| | - Shua J Chai
- California Department of Public Health, Richmond, CA, USA
- U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA
| | - Elsa Villarino
- County of Santa Clara, Public Health Department, Santa Clara, CA, USA
| | - Brandon Bonin
- County of Santa Clara, Public Health Department, Santa Clara, CA, USA
| | | | - Charles Y Chiu
- Department of Laboratory Medicine, University of California, San Francisco, CA, USA.
- UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, CA, USA
- Department of Medicine, Division of Infectious Diseases, University of California, San Francisco, CA, USA
| |
Collapse
|
9
|
Broughton JP, Deng X, Yu G, Fasching CL, Servellita V, Singh J, Miao X, Streithorst JA, Granados A, Sotomayor-Gonzalez A, Zorn K, Gopez A, Hsu E, Gu W, Miller S, Pan CY, Guevara H, Wadford DA, Chen JS, Chiu CY. CRISPR-Cas12-based detection of SARS-CoV-2. Nat Biotechnol 2020; 38:870-874. [PMID: 32300245 PMCID: PMC9107629 DOI: 10.1038/s41587-020-0513-4] [Citation(s) in RCA: 1500] [Impact Index Per Article: 375.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/05/2020] [Accepted: 04/06/2020] [Indexed: 12/26/2022]
Abstract
An outbreak of betacoronavirus severe acute respiratory syndrome (SARS)-CoV-2 began in Wuhan, China in December 2019. COVID-19, the disease associated with SARS-CoV-2 infection, rapidly spread to produce a global pandemic. We report development of a rapid (<40 min), easy-to-implement and accurate CRISPR-Cas12-based lateral flow assay for detection of SARS-CoV-2 from respiratory swab RNA extracts. We validated our method using contrived reference samples and clinical samples from patients in the United States, including 36 patients with COVID-19 infection and 42 patients with other viral respiratory infections. Our CRISPR-based DETECTR assay provides a visual and faster alternative to the US Centers for Disease Control and Prevention SARS-CoV-2 real-time RT-PCR assay, with 95% positive predictive agreement and 100% negative predictive agreement.
Collapse
Affiliation(s)
| | - Xianding Deng
- Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA
- UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, CA, USA
| | - Guixia Yu
- Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA
- UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, CA, USA
| | | | - Venice Servellita
- Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA
- UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, CA, USA
| | - Jasmeet Singh
- Mammoth Biosciences, Inc., South San Francisco, CA, USA
| | - Xin Miao
- Mammoth Biosciences, Inc., South San Francisco, CA, USA
| | - Jessica A Streithorst
- Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA
| | - Andrea Granados
- Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA
- UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, CA, USA
| | - Alicia Sotomayor-Gonzalez
- Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA
- UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, CA, USA
| | - Kelsey Zorn
- Department of Biochemistry and Biophysics, University of California San Francisco, San Francisco, CA, USA
| | - Allan Gopez
- Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA
| | - Elaine Hsu
- Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA
| | - Wei Gu
- Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA
| | - Steve Miller
- Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA
| | - Chao-Yang Pan
- Viral and Rickettsial Disease Laboratory, California Department of Public Health, Richmond, CA, USA
| | - Hugo Guevara
- Viral and Rickettsial Disease Laboratory, California Department of Public Health, Richmond, CA, USA
| | - Debra A Wadford
- Viral and Rickettsial Disease Laboratory, California Department of Public Health, Richmond, CA, USA
| | - Janice S Chen
- Mammoth Biosciences, Inc., South San Francisco, CA, USA.
| | - Charles Y Chiu
- Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA.
- UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, CA, USA.
- Department of Medicine, Division of Infectious Diseases, University of California San Francisco, San Francisco, CA, USA.
| |
Collapse
|
10
|
Broughton JP, Deng X, Yu G, Fasching CL, Servellita V, Singh J, Miao X, Streithorst JA, Granados A, Sotomayor-Gonzalez A, Zorn K, Gopez A, Hsu E, Gu W, Miller S, Pan CY, Guevara H, Wadford DA, Chen JS, Chiu CY. CRISPR-Cas12-based detection of SARS-CoV-2. Nat Biotechnol 2020; 38:870-874. [PMID: 32300245 PMCID: PMC9107629 DOI: 10.1038/s41587-020-0513-4,] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/05/2020] [Accepted: 04/06/2020] [Indexed: 02/02/2024]
Abstract
An outbreak of betacoronavirus severe acute respiratory syndrome (SARS)-CoV-2 began in Wuhan, China in December 2019. COVID-19, the disease associated with SARS-CoV-2 infection, rapidly spread to produce a global pandemic. We report development of a rapid (<40 min), easy-to-implement and accurate CRISPR-Cas12-based lateral flow assay for detection of SARS-CoV-2 from respiratory swab RNA extracts. We validated our method using contrived reference samples and clinical samples from patients in the United States, including 36 patients with COVID-19 infection and 42 patients with other viral respiratory infections. Our CRISPR-based DETECTR assay provides a visual and faster alternative to the US Centers for Disease Control and Prevention SARS-CoV-2 real-time RT-PCR assay, with 95% positive predictive agreement and 100% negative predictive agreement.
Collapse
Affiliation(s)
| | - Xianding Deng
- Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA
- UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, CA, USA
| | - Guixia Yu
- Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA
- UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, CA, USA
| | | | - Venice Servellita
- Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA
- UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, CA, USA
| | - Jasmeet Singh
- Mammoth Biosciences, Inc., South San Francisco, CA, USA
| | - Xin Miao
- Mammoth Biosciences, Inc., South San Francisco, CA, USA
| | - Jessica A Streithorst
- Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA
| | - Andrea Granados
- Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA
- UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, CA, USA
| | - Alicia Sotomayor-Gonzalez
- Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA
- UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, CA, USA
| | - Kelsey Zorn
- Department of Biochemistry and Biophysics, University of California San Francisco, San Francisco, CA, USA
| | - Allan Gopez
- Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA
| | - Elaine Hsu
- Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA
| | - Wei Gu
- Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA
| | - Steve Miller
- Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA
| | - Chao-Yang Pan
- Viral and Rickettsial Disease Laboratory, California Department of Public Health, Richmond, CA, USA
| | - Hugo Guevara
- Viral and Rickettsial Disease Laboratory, California Department of Public Health, Richmond, CA, USA
| | - Debra A Wadford
- Viral and Rickettsial Disease Laboratory, California Department of Public Health, Richmond, CA, USA
| | - Janice S Chen
- Mammoth Biosciences, Inc., South San Francisco, CA, USA.
| | - Charles Y Chiu
- Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA.
- UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, CA, USA.
- Department of Medicine, Division of Infectious Diseases, University of California San Francisco, San Francisco, CA, USA.
| |
Collapse
|
11
|
Karmarkar E, Jain S, Higa J, Fontenot J, Bertolucci R, Huynh T, Hammer G, Brodkin A, Thao M, Brousseau B, Hopkins D, Kelly E, Sheffield M, Henley S, Whittaker H, Herrick RL, Pan CY, Chen A, Kim J, Schaumleffel L, Khwaja Z, Epson E, Chai SJ, Wadford D, Vugia D, Lewis L. Outbreak of Norovirus Illness Among Wildfire Evacuation Shelter Populations - Butte and Glenn Counties, California, November 2018. MMWR Morb Mortal Wkly Rep 2020; 69:613-617. [PMID: 32437337 PMCID: PMC7357343 DOI: 10.15585/mmwr.mm6920a1] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
The Camp Fire, California's deadliest wildfire, began November 8, 2018, and was extinguished November 25 (1). Approximately 1,100 evacuees from the fire sought emergency shelter. On November 10, acute gastroenteritis (AGE) was reported in two evacuation shelters; norovirus illness was suspected, because it is commonly detected in shelter-associated AGE outbreaks. Norovirus is highly contagious and resistant to several disinfectants. Butte County Public Health Department (BCPHD), assisted by the California Department of Public Health (CDPH), initiated active surveillance to identify cases, confirm the etiology, and assess shelter infection prevention and control (IPC) practices to guide recommendations. During November 8-30, a total of 292 patients with AGE were identified among nine evacuation shelters; norovirus was detected in 16 of 17 unique patient stool specimens. Shelter IPC assessments revealed gaps in illness surveillance, isolation practices, cleaning, disinfection, and handwashing. CDPH and BCPHD collaborated with partner agencies to implement AGE screening, institute isolation protocols and 24-hour cleaning services, and promote proper hand hygiene. During disasters with limited resources, damaged infrastructure, and involvement of multiple organizations, establishing shelter disease surveillance and IPC is difficult. However, prioritizing effective surveillance and IPC at shelter activation is necessary to prevent, identify, and contain outbreaks.
Collapse
|
12
|
Deng X, Gu W, Federman S, du Plessis L, Pybus OG, Faria N, Wang C, Yu G, Pan CY, Guevara H, Sotomayor-Gonzalez A, Zorn K, Gopez A, Servellita V, Hsu E, Miller S, Bedford T, Greninger AL, Roychoudhury P, Starita LM, Famulare M, Chu HY, Shendure J, Jerome KR, Anderson C, Gangavarapu K, Zeller M, Spencer E, Andersen KG, MacCannell D, Paden CR, Li Y, Zhang J, Tong S, Armstrong G, Morrow S, Willis M, Matyas BT, Mase S, Kasirye O, Park M, Chan C, Yu AT, Chai SJ, Villarino E, Bonin B, Wadford DA, Chiu CY. A Genomic Survey of SARS-CoV-2 Reveals Multiple Introductions into Northern California without a Predominant Lineage. medRxiv 2020. [PMID: 32511579 PMCID: PMC7276006 DOI: 10.1101/2020.03.27.20044925] [Citation(s) in RCA: 17] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
The COVID-19 pandemic caused by the novel coronavirus SARS-CoV-2 has spread globally, resulting in >300,000 reported cases worldwide as of March 21st, 2020. Here we investigate the genetic diversity and genomic epidemiology of SARS-CoV-2 in Northern California using samples from returning travelers, cruise ship passengers, and cases of community transmission with unclear infection sources. Virus genomes were sampled from 29 patients diagnosed with COVID-19 infection from Feb 3rd through Mar 15th. Phylogenetic analyses revealed at least 8 different SARS-CoV-2 lineages, suggesting multiple independent introductions of the virus into the state. Virus genomes from passengers on two consecutive excursions of the Grand Princess cruise ship clustered with those from an established epidemic in Washington State, including the WA1 genome representing the first reported case in the United States on January 19th. We also detected evidence for presumptive transmission of SARS-CoV-2 lineages from one community to another. These findings suggest that cryptic transmission of SARS-CoV-2 in Northern California to date is characterized by multiple transmission chains that originate via distinct introductions from international and interstate travel, rather than widespread community transmission of a single predominant lineage. Rapid testing and contact tracing, social distancing, and travel restrictions are measures that will help to slow SARS-CoV-2 spread in California and other regions of the USA.
Collapse
Affiliation(s)
- Xianding Deng
- Department of Laboratory Medicine, University of California, San Francisco, California, USA.,UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, California, USA
| | - Wei Gu
- Department of Laboratory Medicine, University of California, San Francisco, California, USA.,UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, California, USA
| | - Scot Federman
- Department of Laboratory Medicine, University of California, San Francisco, California, USA.,UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, California, USA
| | | | | | - Nuno Faria
- Department of Zoology, University of Oxford, Oxford, UK
| | - Candace Wang
- Department of Laboratory Medicine, University of California, San Francisco, California, USA.,UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, California, USA
| | - Guixia Yu
- Department of Laboratory Medicine, University of California, San Francisco, California, USA.,UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, California, USA
| | - Chao-Yang Pan
- California Department of Public Health, Richmond, California, USA
| | - Hugo Guevara
- California Department of Public Health, Richmond, California, USA
| | - Alicia Sotomayor-Gonzalez
- Department of Laboratory Medicine, University of California, San Francisco, California, USA.,UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, California, USA
| | - Kelsey Zorn
- Department of Biochemistry and Biophysics, San Francisco, California, USA
| | - Allan Gopez
- Department of Laboratory Medicine, University of California, San Francisco, California, USA
| | - Venice Servellita
- Department of Laboratory Medicine, University of California, San Francisco, California, USA
| | - Elaine Hsu
- Department of Laboratory Medicine, University of California, San Francisco, California, USA
| | - Steve Miller
- Department of Laboratory Medicine, University of California, San Francisco, California, USA
| | - Trevor Bedford
- Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.,Brotman Baty Institute for Precision Medicine, Seattle, Washington, USA
| | - Alexander L Greninger
- Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.,Department of Laboratory Medicine, University of Washington, Seattle, WA, USA
| | - Pavitra Roychoudhury
- Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.,Department of Laboratory Medicine, University of Washington, Seattle, WA, USA
| | - Lea M Starita
- Brotman Baty Institute for Precision Medicine, Seattle, Washington, USA.,Department of Genome Sciences, University of Washington, Seattle, WA, USA
| | | | - Helen Y Chu
- Brotman Baty Institute for Precision Medicine, Seattle, Washington, USA.,Department of Medicine, University of Washington, Seattle, WA, USA
| | - Jay Shendure
- Brotman Baty Institute for Precision Medicine, Seattle, Washington, USA.,Department of Laboratory Medicine, University of Washington, Seattle, WA, USA.,Howards Hughes Medical Institute, Seattle, WA, USA
| | - Keith R Jerome
- Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.,Department of Laboratory Medicine, University of Washington, Seattle, WA, USA
| | - Catie Anderson
- Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA
| | - Karthik Gangavarapu
- Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA
| | - Mark Zeller
- Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA
| | - Emily Spencer
- Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA
| | - Kristian G Andersen
- Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA
| | - Duncan MacCannell
- United States Centers for Disease Control and Prevention, Atlanta, Georgia, USA
| | - Clinton R Paden
- United States Centers for Disease Control and Prevention, Atlanta, Georgia, USA
| | - Yan Li
- United States Centers for Disease Control and Prevention, Atlanta, Georgia, USA
| | - Jing Zhang
- United States Centers for Disease Control and Prevention, Atlanta, Georgia, USA
| | - Suxiang Tong
- United States Centers for Disease Control and Prevention, Atlanta, Georgia, USA
| | - Gregory Armstrong
- United States Centers for Disease Control and Prevention, Atlanta, Georgia, USA
| | - Scott Morrow
- San Mateo County Department of Public Health, San Mateo, California, USA
| | - Matthew Willis
- Marin County Division of Public Health, San Rafael, California, USA
| | - Bela T Matyas
- Solano County Department of Public Health, Fairfield, California, USA
| | - Sundari Mase
- Sonoma County Department of Public Health, Santa Rosa, California, USA
| | - Olivia Kasirye
- Sacramento County Division of Public Health, Sacramento, California, USA
| | - Maggie Park
- San Joaquin County Department of Public Health, Stockton, California, USA
| | - Curtis Chan
- San Francisco County Department of Public Health, San Francisco, California, USA
| | - Alexander T Yu
- California Department of Public Health, Richmond, California, USA
| | - Shua J Chai
- California Department of Public Health, Richmond, California, USA.,United States Centers for Disease Control and Prevention, Atlanta, Georgia, USA
| | - Elsa Villarino
- Santa Clara County Department of Public Health, Santa Clara, California, USA
| | - Brandon Bonin
- Santa Clara County Department of Public Health, Santa Clara, California, USA
| | - Debra A Wadford
- California Department of Public Health, Richmond, California, USA
| | - Charles Y Chiu
- Department of Laboratory Medicine, University of California, San Francisco, California, USA.,UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, California, USA.,Department of Medicine, Division of Infectious Diseases, University of California, San Francisco, California, USA
| |
Collapse
|
13
|
Broughton JP, Deng X, Yu G, Fasching CL, Singh J, Streithorst J, Granados A, Sotomayor-Gonzalez A, Zorn K, Gopez A, Hsu E, Gu W, Miller S, Pan CY, Guevara H, Wadford DA, Chen JS, Chiu CY. Rapid Detection of 2019 Novel Coronavirus SARS-CoV-2 Using a CRISPR-based DETECTR Lateral Flow Assay. medRxiv 2020:2020.03.06.20032334. [PMID: 32511449 PMCID: PMC7239074 DOI: 10.1101/2020.03.06.20032334] [Citation(s) in RCA: 62] [Impact Index Per Article: 15.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
An outbreak of novel betacoronavirus, SARS-CoV-2 (formerly named 2019-nCoV), began in Wuhan, China in December 2019 and the COVID-19 disease associated with infection has since spread rapidly to multiple countries. Here we report the development of SARS-CoV-2 DETECTR, a rapid (~30 min), low-cost, and accurate CRISPR-Cas12 based lateral flow assay for detection of SARS-CoV-2 from respiratory swab RNA extracts. We validated this method using contrived reference samples and clinical samples from infected US patients and demonstrated comparable performance to the US CDC SARS-CoV-2 real-time RT-PCR assay.
Collapse
Affiliation(s)
| | - Xianding Deng
- Department of Laboratory Medicine, University of California, San Francisco, California, USA
- UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, California, USA
| | - Guixia Yu
- Department of Laboratory Medicine, University of California, San Francisco, California, USA
- UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, California, USA
| | | | - Jasmeet Singh
- Mammoth Biosciences, Inc., San Francisco, California, USA
| | - Jessica Streithorst
- Department of Laboratory Medicine, University of California, San Francisco, California, USA
| | - Andrea Granados
- Department of Laboratory Medicine, University of California, San Francisco, California, USA
- UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, California, USA
| | - Alicia Sotomayor-Gonzalez
- Department of Laboratory Medicine, University of California, San Francisco, California, USA
- UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, California, USA
| | - Kelsey Zorn
- Department of Biochemistry and Biophysics, San Francisco, California, USA
| | - Allan Gopez
- Department of Laboratory Medicine, University of California, San Francisco, California, USA
| | - Elaine Hsu
- Department of Laboratory Medicine, University of California, San Francisco, California, USA
| | - Wei Gu
- Department of Laboratory Medicine, University of California, San Francisco, California, USA
| | - Steve Miller
- Department of Laboratory Medicine, University of California, San Francisco, California, USA
| | - Chao-Yang Pan
- Viral and Rickettsial Disease Laboratory, California Department of Public Health, Richmond, CA, USA
| | - Hugo Guevara
- Viral and Rickettsial Disease Laboratory, California Department of Public Health, Richmond, CA, USA
| | - Debra A. Wadford
- Viral and Rickettsial Disease Laboratory, California Department of Public Health, Richmond, CA, USA
| | - Janice S. Chen
- Mammoth Biosciences, Inc., San Francisco, California, USA
| | - Charles Y. Chiu
- Department of Laboratory Medicine, University of California, San Francisco, California, USA
- UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, California, USA
- Department of Medicine, Division of Infectious Diseases, University of California, San Francisco, California, USA
| |
Collapse
|
14
|
OYong K, Killerby M, Pan CY, Huynh T, Green NM, Wadford DA, Terashita D. Outbreak of Epidemic Keratoconjunctivitis Caused by Human Adenovirus Type D53 in an Eye Care Clinic - Los Angeles County, 2017. MMWR Morb Mortal Wkly Rep 2018; 67:1347-1349. [PMID: 30521501 PMCID: PMC6329482 DOI: 10.15585/mmwr.mm6748a4] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
On June 22, 2017, the Los Angeles County Department of Public Health (LAC DPH) was notified of seven patients who were seen at an eye care clinic on June 8, 2017, and later developed symptoms of epidemic keratoconjunctivitis (EKC). EKC is a contagious, severe form of viral conjunctivitis that can cause pain and blurred vision for up to 4 weeks (1). LAC DPH conducted an investigation, which identified 17 patients with EKC, including 15 who had visited the optometry clinic and two who were household contacts of clinic patients. Observations in the clinic found deficiencies in disinfection of tonometers (an instrument connected to a slit lamp and used to test for glaucoma by measuring intraocular pressure) and multiuse eye drop administration. Staff member education and revision of disinfection practices interrupted further transmission. Patient specimens tested positive for human adenovirus (HAdV) type D53 (HAdV-53). As the first documented EKC outbreak associated with HAdV-D53 in the United States, this outbreak highlights the need for rigorous implementation of recommended infection prevention practices in eye care settings.
Collapse
|
15
|
Diez-Valcarce M, Castro CJ, Marine RL, Halasa N, Mayta H, Saito M, Tsaknaridis L, Pan CY, Bucardo F, Becker-Dreps S, Lopez MR, Magaña LC, Ng TFF, Vinjé J. Genetic diversity of human sapovirus across the Americas. J Clin Virol 2018; 104:65-72. [PMID: 29753103 DOI: 10.1016/j.jcv.2018.05.003] [Citation(s) in RCA: 36] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2018] [Revised: 04/24/2018] [Accepted: 05/04/2018] [Indexed: 12/20/2022]
Abstract
BACKGROUND Sapoviruses are responsible for sporadic and epidemic acute gastroenteritis worldwide. Sapovirus typing protocols have a success rate as low as 43% and relatively few complete sapovirus genome sequences are available to improve current typing protocols. OBJECTIVE/STUDY DESIGN To increase the number of complete sapovirus genomes to better understand the molecular epidemiology of human sapovirus and to improve the success rate of current sapovirus typing methods, we used deep metagenomics shotgun sequencing to obtain the complete genomes of 68 sapovirus samples from four different countries across the Americas (Guatemala, Nicaragua, Peru and the US). RESULTS VP1 genotyping showed that all sapovirus sequences could be grouped in the four established genogroups (GI (n = 13), GII (n = 30), GIV (n = 23), GV (n = 2)) that infect humans. They include the near-complete genome of a GI.6 virus and a recently reported novel GII.8 virus. Sequences of the complete RNA-dependent RNA polymerase gene could be grouped into three major genetic clusters or polymerase (P) types (GI.P, GII.P and GV.P) with all GIV viruses harboring a GII polymerase. One (GII.P-GII.4) of the new 68 sequences was a recombinant virus with the hotspot between the NS7 and VP1 regions. CONCLUSIONS Analyses of this expanded database of near-complete sapovirus sequences showed several mismatches in the genotyping primers, suggesting opportunities to revisit and update current sapovirus typing methods.
Collapse
Affiliation(s)
| | | | - Rachel L Marine
- Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
| | | | - Holger Mayta
- Department of Cellular and Molecular Sciences, Facultad de Ciencias y Filosofía, Universidad Peruana Cayetano Heredia, Lima, Peru
| | - Mayuko Saito
- Department of Cellular and Molecular Sciences, Facultad de Ciencias y Filosofía, Universidad Peruana Cayetano Heredia, Lima, Peru; Department of Virology, Tohoku University, Graduate School of Medicine, Sendai, Japan
| | | | - Chao-Yang Pan
- California Department of Public Health, Richmond, CA, USA
| | - Filemon Bucardo
- Department of Microbiology, University of Leon, Leon, Nicaragua
| | - Sylvia Becker-Dreps
- Department of Family Medicine and Epidemiology, University of North Carolina, Chapel Hill, NC, USA
| | | | | | - Terry Fei Fan Ng
- Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
| | - Jan Vinjé
- Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
| |
Collapse
|
16
|
Burke RM, Tate JE, Barin N, Bock C, Bowen MD, Chang D, Gautam R, Han G, Holguin J, Huynh T, Pan CY, Quenelle R, Sallenave C, Torres C, Wadford D, Parashar U. Three Rotavirus Outbreaks in the Postvaccine Era - California, 2017. MMWR Morb Mortal Wkly Rep 2018; 67:470-472. [PMID: 29698381 PMCID: PMC5919604 DOI: 10.15585/mmwr.mm6716a3] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
17
|
Li LL, Zhao L, Dou JT, Yang GQ, Gu WJ, Lü ZH, Ba JM, Mu YM, Lu JM, Pan CY. [Surgery versus conservative management for subclinical Cushing's syndrome in adrenal incidentalomas]. Zhonghua Yi Xue Za Zhi 2017; 97:3152-3157. [PMID: 29081161 DOI: 10.3760/cma.j.issn.0376-2491.2017.40.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To determine the effect of the surgical and conservative approaches on the metabolic profiles in patients with subclinical Cushing's syndrome (SCS) in adrenal incidentalomas (AI). Methods: A hundred and thirty AI patients with SCS in Department of Endocrinology, PLA General Hospital between January 2008 and December 2016 were studied, surgery was performed in 88 patients (surgical group), and the rest received conservative approach (conservative group). The improvement/worsening of blood pressure, blood glucose, lipid profiles and body weight after a duration of >18 months follow-up were analyzed, respectively. Results: Baseline demographics, clinical characteristics were similar between surgical and conservative groups. In the surgical group, blood pressure, blood glucose, lipid profiles and body weight improved more frequently than that in conservative group (29.69% vs 3.12%, P=0.003; 10.94% vs 3.12%, P=0.262; 7.81% vs 3.12%, P=0.660; 39.06% vs 9.38%, P=0.004, respectively). In conservative group, blood pressure, blood glucose, lipid profiles and body weight worsened more frequently than that in surgical group (28.13% vs 0, P<0.001; 25.0% vs 0, P<0.001; 18.75% vs 0, P=0.003; 40.62% vs 20.31%, P=0.051, respectively). Logistic regression analysis indicated surgical treatment was associated with improvement of blood pressure (OR=10.687, 95%CI: 1.279-89.299) and weight loss (OR=5.541, 95%CI: 1.404-21.872) independently of gender, age, duration of follow-up, serum cortisol level after 1 mg-dexamethasone suppression test and the mass size. Conclusion: In AI patients with SCS, surgery was beneficial in the aspect of metabolic profiles.
Collapse
Affiliation(s)
- L L Li
- Department of Endocrinology, PLA General Hospital, Beijing 100853, China
| | - L Zhao
- Department of Endocrinology, PLA Lanzhou General Hospital, Lanzhou 730030, China
| | | | | | | | | | | | | | | | | |
Collapse
|
18
|
Mu YM, Guo LX, Li L, Li YM, Xu XJ, Li QM, Xu MT, Zhu LY, Yuan GY, Liu Y, Xu C, Wang ZJ, Shen FX, Luo Y, Liu JY, Li QF, Wang WH, Lai XY, Xu HF, Pan CY. [The efficacy and safety of insulin degludec versus insulin glargine in insulin-naive subjects with type 2 diabetes: results of a Chinese cohort from a multinational randomized controlled trial]. Zhonghua Nei Ke Za Zhi 2017; 56:660-666. [PMID: 28870034 DOI: 10.3760/cma.j.issn.0578-1426.2017.09.008] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
Objective: To compare the safety and efficacy of insulin degludec (IDeg) with those of insulin glargine (IGlar) in insulin-naive subjects with type 2 diabetes (T2DM). Methods: This was a 26-week, randomized, open-label, parallel-group, treat-to-target trial in 560 Chinese subjects with T2DM (men/women: 274/263, mean age 56 years, mean diabetes duration 7 years) inadequately controlled on oral antidiabetic drugs (OADs). Subjects were randomized 2∶1 to once-daily IDeg (373 subjects) or IGlar(187 subjects), both in combination with metformin. The primary endpoint was changes from baseline in glycosylated hemoglobin(HbA1c) after 26 weeks. Results: Mean HbA1c decreased from 8.2% in both groups to 6.9% in IDeg and 7.0% in IGlar, respectively. Estimated treatment difference (ETD) of IDeg-IGlar in change from baseline was -0.10% points (95%CI-0.25-0.05). The proportion of subjects achieving HbA1c<7.0% was 56.3%and 49.7% with IDeg and IGlar, respectively [estimated odds ratio of IDeg/IGlar: 1.26(95%CI 0.88-1.82)]. Numerically lower rateof overall confirmed hypoglycaemia and statistically significantly lower nocturnal confirmed hypoglycemia were associated with IDeg compared with IGlar, respectively [estimated rateratio of IDeg/IGlar 0.69(95%CI 0.46-1.03), and 0.43(95%CI 0.19-0.97)]. No differences in other safety parameters were found between the two groups. Conclusions: IDeg was non-inferior to IGlar in terms of glycaemic control, and was associated with a statistically significantly lower rate of nocturnal confirmed hypoglycaemia. IDeg is considered to be suitable for initiating insulin therapy in Chinese T2DM patients on OADs requiring intensified treatment. Clinical trail registration: Clinicaltrials.gov, NCT01849289.
Collapse
Affiliation(s)
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | - C Y Pan
- Department of Endocrinology, Chinese PLA General Hospital, Beijing 100853, China
| |
Collapse
|
19
|
He BL, Xu N, Li YL, Pan CY, Cao R, Liao LB, Yin CX, Lan YQ, Lu ZY, Huang JX, Zhou HS, Liu QF, Liu XL. [Clinical analysis of adult Philadelphia chromosome-positive acute lymphoblastic leukemia with p16 gene deletion]. Zhonghua Xue Ye Xue Za Zhi 2017; 38:204-209. [PMID: 28395443 PMCID: PMC7348375 DOI: 10.3760/cma.j.issn.0253-2727.2017.03.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
Abstract
目的 探讨p16基因缺失在成人Ph染色体阳性急性淋巴细胞白血病(Ph+ ALL)中的临床意义。 方法 回顾性分析80例Ph+ALL伴p16基因缺失患者的临床特征、免疫表型、细胞遗传学、分子生物学改变及其预后。 结果 31.3% Ph+ALL患者合并p16基因缺失;p16基因缺失组与非缺失组相比,初诊时高白细胞计数(WBC≥30×109/L)更常见,高表达CD20,更易出现附加染色体异常,其中以累及7、8、19号染色体以及der(22)较为常见;两组诱导缓解率比较差异无统计学意义(P=0.033),p16基因缺失组患者治疗3个疗程后获BCR-ABL融合基因主要分子学反应(MMR)率和完全分子学反应(CMR)率均明显低于非缺失组(P值分别为0.034和0.036),且复发率明显高于非缺失组(P=0.033);p16基因缺失组使用伊马替尼联合化疗者和使用达沙替尼联合化疗者的MMR、CMR率及复发率差异均无统计学意义(P值均>0.05);p16基因缺失组患者3年总体生存(OS)率及无病生存(DFS)率分别为37.1%和12.4%,显著低于非缺失组的54.1%和45.9%(P值分别为0.037和0.026);25例p16基因缺失患者中14例行异基因造血干细胞移植(allo-HSCT),其中位OS时间为21个月,明显长于非移植组患者的12个月(P=0.030)。 结论 成人Ph+ALL伴p16基因缺失患者预后相对较差,二代酪氨酸激酶抑制剂不能明显改善其疗效,但allo-HSCT能够改善部分患者的生存,明确p16基因缺失状态对于评估预后和指导临床治疗有重要意义。
Collapse
Affiliation(s)
- B L He
- Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
20
|
Pan CY, Xu N, He BL, Cao R, Liao LB, Yin CX, Lan YQ, Lu ZY, Huang JX, Sun J, Feng R, Liu QF, Liu XL. [Clinical significance of cytogenetic monitoring in chronic myeloid leukemia]. Zhonghua Xue Ye Xue Za Zhi 2017; 38:112-117. [PMID: 28279034 PMCID: PMC7354167 DOI: 10.3760/cma.j.issn.0253-2727.2017.02.006] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
Abstract
Objective: To analyze the association of cytogenetic abnormalities with the prognosis of chronic myeloid leukemia (CML) patients in tyrosine kinase inhibitors (TKI) era. Methods: Karyotype analysis of chromosome G-banding was carried out in 387 newly diagnosed CML patients by short-term culture of bone marrow cells. The correlation of cytogenetic abnormalities and CML progression was explored in combination with ABL tyrosine point mutations. Result: Of 387 patients with positive BCR-ABL fusion gene assayed by fluorescence in situ hybridization (FISH) technique, 94.1% (364/387) patients were Ph positive and 5.9% (23/387) Ph negative; 320 patients (87.9%) had a translocation t (9;22) (q34;q11) and 5 (1.4%) a variant translocation t (v;22) . Additional cytogenetic aberrations (ACA) at diagnosis were found in 10.7% (39/387) Ph(+) patients, major route ACA in 22 (56.4%) cases and minor route ACA in 15 (38.5%) cases and 2 patients (5.1%) lacked the Y chromosome (-Y) ; 23.4% (71/303) patients occurred ACA during TKI treatment and the most frequent abnormalities were abnormal chromosome numbersd, which were likely associated with high proportion of disease progression (χ(2)=168.21, P<0.001) and ABL tyrosine point mutations (χ(2)=29.04, P<0.001) . Newly diagnosed CML-CP patients with t (9;22) (q34;q11) had a longer event-free survival (EFS) and disease-free survival (DFS) rates than that of patients with ACA (P=0.037; P=0.003) , while the overall survival (OS) had no significant differences (P=0.209) . As for CML-CP patients that occurred ACA during TKI therapy would have a marked low OS, EFS and DFS (all P<0.001) compared with no ACA occurred patients. Survival of advanced patients that occurred ACA were dramatically reduced. Conclusion: ACA often emerged during the disease progress in CML patients, regular and timely detection of chromosomes karyotype and ABL tyrosine point mutations during TKI treatment was important for therapeutic evaluation, progress and prognosis of CML.
Collapse
Affiliation(s)
- C Y Pan
- Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
21
|
Huang YW, Pan CY, Hsiao YY, Chao TC, Lee CC, Tung CJ. Monte Carlo simulations of the relative biological effectiveness for DNA double strand breaks from 300 MeV u(-1) carbon-ion beams. Phys Med Biol 2015; 60:5995-6012. [PMID: 26183156 DOI: 10.1088/0031-9155/60/15/5995] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
Monte Carlo simulations are used to calculate the relative biological effectiveness (RBE) of 300 MeV u(-1) carbon-ion beams at different depths in a cylindrical water phantom of 10 cm radius and 30 cm long. RBE values for the induction of DNA double strand breaks (DSB), a biological endpoint closely related to cell inactivation, are estimated for monoenergetic and energy-modulated carbon ion beams. Individual contributions to the RBE from primary ions and secondary nuclear fragments are simulated separately. These simulations are based on a multi-scale modelling approach by first applying the FLUKA (version 2011.2.17) transport code to estimate the absorbed doses and fluence energy spectra, then using the MCDS (version 3.10A) damage code for DSB yields. The approach is efficient since it separates the non-stochastic dosimetry problem from the stochastic DNA damage problem. The MCDS code predicts the major trends of the DSB yields from detailed track structure simulations. It is found that, as depth is increasing, RBE values increase slowly from the entrance depth to the plateau region and change substantially in the Bragg peak region. RBE values reach their maxima at the distal edge of the Bragg peak. Beyond this edge, contributions to RBE are entirely from nuclear fragments. Maximum RBE values at the distal edges of the Bragg peak and the spread-out Bragg peak are, respectively, 3.0 and 2.8. The present approach has the flexibility to weight RBE contributions from different DSB classes, i.e. DSB0, DSB+ and DSB++.
Collapse
Affiliation(s)
- Y W Huang
- Department of Medical Imaging and Radiological Sciences, College of Medicine, Chang Gung University, Kweishan Taoyuan, Taiwan
| | | | | | | | | | | |
Collapse
|
22
|
Chang CF, Zhao WM, Mei JX, Zhou Y, Pan CY, Xu TT, Xu CS. Branches of NF-κb signaling pathway regulate hepatocyte proliferation in rat liver regeneration. Genet Mol Res 2015. [PMID: 26214444 DOI: 10.4238/2015.july.13.9] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
Previous studies have demonstrated that the nuclear factor κB (NF-κB) pathway is involved in promoting cell proliferation. To further explore the regulatory branches and their sequence in the NF-κB pathway in the promotion of hepatocyte proliferation at the transcriptional level during rat liver regeneration, Rat Genome 230 2.0 array was used to detect the expression changes of the isolated hepatocytes. We found that many genes involved in the NF-κB pathway (including 73 known genes and 19 homologous genes) and cell proliferation (including 484 genes and 104 homologous genes) were associated with liver regeneration. Expression profile function (Ep) was used to analyze the biological processes. It was revealed that the NF-κB pathway promoted hepatocyte proliferation through three branches. Several methods of integrated statistics were applied to extract and screen key genes in liver regeneration, and it indicated that eight genes may play a vital role in rat liver regeneration. To confirm the above predicted results, Ccnd1, Jun and Myc were analyzed using qRT-PCR, and the results were generally consistent with that of microarray data. It is concluded that 3 branches and 8 key genes involved in the NF-κB pathway regulate hepatocyte proliferation during rat liver regeneration.
Collapse
Affiliation(s)
- C F Chang
- College of Life Science, Henan Normal University, Xinxiang, China
| | - W M Zhao
- College of Life Science, Henan Normal University, Xinxiang, China
| | - J X Mei
- College of Life Science, Henan Normal University, Xinxiang, China
| | - Y Zhou
- College of Life Science, Henan Normal University, Xinxiang, China
| | - C Y Pan
- College of Life Science, Henan Normal University, Xinxiang, China
| | - T T Xu
- College of Life Science, Henan Normal University, Xinxiang, China
| | - C S Xu
- College of Life Science, Henan Normal University, Xinxiang, China
| |
Collapse
|
23
|
Rong XJ, Xu YJ, Wang QY, Liao MJ, Liu XZ, Pan CY, Zhang Z, Wang YG. Isolation and characterization of polymorphic microsatellite markers from Coilia ectenes. Genet Mol Res 2013; 12:6011-7. [PMID: 24338395 DOI: 10.4238/2013.november.26.11] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
Coilia ectenes (Jordan and Seale 1905) is an important anadromous species that is an important resource at risk of extinction because of over-fishing, pollution, and coastal construction. To evaluate the genetic diversity of C. ectenes for use in breeding programs, elite microsatellite-enriched libraries were constructed and novel microsatellite markers were developed, and applied to genetically detect wild populations. Out of 92 randomly selected and sequenced clones, 89 contained a CA or GA repeat motif. Twenty-two pairs of primers were designed to investigate the polymorphism and genetic structure of a wild population collected from the Yellow River estuary, China. It was found that 2 loci were monomorphic and 20 loci were polymorphic. The number of alleles per polymorphic loci ranged from 3 to 13, with an average of 7.9. The expected heterozygosity per locus ranged from 0.05 to 0.89, with an average of 0.68. The isolated polymorphic markers are expected to be of use in future genetic breeding programs for C. ectenes, and in the assessment of genetic variation within this species.
Collapse
Affiliation(s)
- X J Rong
- Ocean University of China, Qingdao, China
| | | | | | | | | | | | | | | |
Collapse
|
24
|
Khunti K, Damci T, Meneghini L, Pan CY, Yale JF. Study of Once Daily Levemir (SOLVE™): insights into the timing of insulin initiation in people with poorly controlled type 2 diabetes in routine clinical practice. Diabetes Obes Metab 2012; 14:654-61. [PMID: 22443213 DOI: 10.1111/j.1463-1326.2012.01602.x] [Citation(s) in RCA: 90] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Abstract
AIMS The aim of this analysis is to determine the timing of insulin initiation in routine clinical practice, especially in relation to glycaemic control and use of oral antidiabetic drugs (OADs). METHODS Study of Once Daily Levemir was a 24-week international observational study involving 10 countries which evaluated the safety and effectiveness of initiating once-daily insulin detemir in people with type 2 diabetes mellitus (T2DM) being treated with one or more OADs (clinical trial number NCT00825643 and NCT00740519). RESULTS A total of 17 374 participants were enrolled in the study: aged 62 ± 12 years, 53% male, T2DM duration 10 ± 7 years, body mass index 29.3 ± 5.4 kg/m(2) . Pre-insulin HbA1c was 8.9 ± 1.6%. The proportion of patients with HbA1c ≥9.0% ranged from 64% (UK) to 23% (Poland). Pre-insulin OAD treatment included metformin (81%), sulphonylureas (59%), glinides (16%), thiazolidinediones (TZD) (12%), α-glucosidase inhibitors (12%) and dipeptidyl peptidase (DPP)-IV inhibitors (7%). The mean starting dose of insulin detemir for the total cohort was 0.16 ± 0.09 U/kg. Differences in OAD use and insulin doses at initiation were evident among participating countries. The largest proportional changes in OAD prescribing at insulin initiation were seen with glinides (+15%), sulphonylureas (-19%), TZD (-31%) and DPP-IV inhibitors (-28%). CONCLUSIONS Despite well-documented benefits of timely glycaemic control and consensus guidelines encouraging earlier use of insulin, considerable clinical inertia exists with respect to initiating appropriate insulin therapy in people with T2DM. Considerable regional differences exist in the timing of insulin initiation and in the use of OADs.
Collapse
Affiliation(s)
- K Khunti
- Department of Health Sciences, University of Leicester, 4301 Connecticut Ave. NW, Washington, DC 20008, USA.
| | | | | | | | | |
Collapse
|
25
|
Storms AD, Gubareva LV, Su S, Wheeling JT, Okomo-Adhiambo M, Pan CY, Reisdorf E, St George K, Myers R, Wotton JT, Robinson S, Leader B, Thompson M, Shannon M, Klimov A, Fry AM. Oseltamivir-resistant pandemic (H1N1) 2009 virus infections, United States, 2010-11. Emerg Infect Dis 2012; 18:308-11. [PMID: 22305467 PMCID: PMC3310472 DOI: 10.3201/eid1802.111466] [Citation(s) in RCA: 83] [Impact Index Per Article: 6.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
Abstract
During October 2010–July 2011, 1.0% of pandemic (H1N1) 2009 viruses in the United States were oseltamivir resistant, compared with 0.5% during the 2009–10 influenza season. Of resistant viruses from 2010–11 and 2009–10, 26% and 89%, respectively, were from persons exposed to oseltamivir before specimen collection. Findings suggest limited community transmission of oseltamivir-resistant virus.
Collapse
Affiliation(s)
- Aaron D Storms
- Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
26
|
Kengne AP, Patel A, Colagiuri S, Heller S, Hamet P, Marre M, Pan CY, Zoungas S, Grobbee DE, Neal B, Chalmers J, Woodward M. The Framingham and UK Prospective Diabetes Study (UKPDS) risk equations do not reliably estimate the probability of cardiovascular events in a large ethnically diverse sample of patients with diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron-MR Controlled Evaluation (ADVANCE) Study. Diabetologia 2010; 53:821-31. [PMID: 20157695 DOI: 10.1007/s00125-010-1681-4] [Citation(s) in RCA: 96] [Impact Index Per Article: 6.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/08/2009] [Accepted: 01/14/2010] [Indexed: 02/04/2023]
Abstract
AIMS/HYPOTHESIS Available multivariable equations for cardiovascular risk assessment in people with diabetes have been derived either from the general population or from populations with diabetes. Their utility and comparative performance in a contemporary group of patients with type 2 diabetes are not well established. The aim of this study was to evaluate the performance of the Framingham and UK Prospective Diabetes Study (UKPDS) risk equations in participants who took part in the Action in Diabetes and Vascular disease: Preterax and Diamicron-MR Controlled Evaluation (ADVANCE) trial. METHODS The 4-year risks of cardiovascular disease (CVD) and its constituents were estimated using two published Framingham and the UKPDS risk equations in 7,502 individuals with type 2 diabetes without prior known CVD at their enrolment in the trial. RESULTS The risk of major CVD was overestimated by 170% (95% CI 146-195%) and 202% (176-231%) using the two Framingham equations. The risk of major coronary heart disease was overestimated by 198% (162-238%) with the UKPDS, and by 146% (117-179%) and 289% (243-341%) with the two different Framingham equations, respectively. The risks of stroke events were also overestimated with the UKPDS and one of the Framingham equations. The ability of these equations to rank risk among ADVANCE participants was modest, with c-statistics ranging from 0.57 to 0.71. Results stratified by sex, treatment allocation and ethnicity were broadly similar. CONCLUSIONS/INTERPRETATION Application of the Framingham and UKPDS risk equations to a contemporary treated group of patients with established type 2 diabetes is likely to substantially overestimate cardiovascular risk.
Collapse
Affiliation(s)
- A P Kengne
- The George Institute for International Health, University of Sydney, PO Box M201, Level 10 KGV Building, RPAH, Missenden Road, Camperdown, Sydney, NSW 2050, Australia.
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
27
|
de Galan BE, Zoungas S, Chalmers J, Anderson C, Dufouil C, Pillai A, Cooper M, Grobbee DE, Hackett M, Hamet P, Heller SR, Lisheng L, MacMahon S, Mancia G, Neal B, Pan CY, Patel A, Poulter N, Travert F, Woodward M. Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial. Diabetologia 2009; 52:2328-2336. [PMID: 19688336 DOI: 10.1007/s00125-009-1484-7] [Citation(s) in RCA: 147] [Impact Index Per Article: 9.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/29/2009] [Accepted: 07/13/2009] [Indexed: 12/20/2022]
Abstract
AIMS/HYPOTHESIS The relationship between cognitive function, cardiovascular disease and premature death is not well established in patients with type 2 diabetes. We assessed the effects of cognitive function in 11,140 patients with type 2 diabetes who participated in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial. Furthermore, we tested whether level of cognitive function altered the beneficial effects of the BP-lowering and glycaemic-control regimens in the trial. METHODS Cognitive function was assessed using the Mini Mental State Examination at baseline, and defined by scores 28-30 ('normal', n = 8,689), 24-27 ('mild dysfunction', n = 2,231) and <24 ('severe dysfunction', n = 212). Risks of major cardiovascular events, death and hypoglycaemia and interactions with treatment were assessed using Cox proportional hazards analysis. RESULTS Relative to normal function, both mild and severe cognitive dysfunction significantly increased the multiple-adjusted risks of major cardiovascular events (HR 1.27, 95% CI 1.11-1.46 and 1.42, 95% CI 1.01-1.99; both p < 0.05), cardiovascular death (1.41, 95% CI 1.16-1.71 and 1.56, 95% CI 0.99-2.46; both p <or= 0.05) and all-cause death (1.33, 95% CI 1.16-1.54 and 1.50, 95% CI 1.06-2.12; both p < 0.03). Severe, but not mild, cognitive dysfunction increased the risk of severe hypoglycaemia (HR 2.10, 95% CI 1.14-3.87; p = 0.018). There was no evidence of heterogeneity of treatment effects on cardiovascular outcomes in subgroups defined by cognitive function at baseline. CONCLUSIONS/INTERPRETATION Cognitive dysfunction is an independent predictor of clinical outcomes in patients with type 2 diabetes, but does not modify the effects of BP lowering or glucose control on the risks of major cardiovascular events. TRIAL REGISTRATION ClinicalTrials.gov NCT00145925.
Collapse
Affiliation(s)
- B E de Galan
- The George Institute for International Health, The University of Sydney, PO Box M201, Missenden Road, Camperdown, Sydney, NSW, 2050, Australia
- Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands
| | - S Zoungas
- The George Institute for International Health, The University of Sydney, PO Box M201, Missenden Road, Camperdown, Sydney, NSW, 2050, Australia.
- Monash University, Melbourne, VIC, Australia.
| | - J Chalmers
- The George Institute for International Health, The University of Sydney, PO Box M201, Missenden Road, Camperdown, Sydney, NSW, 2050, Australia
| | - C Anderson
- The George Institute for International Health, The University of Sydney, PO Box M201, Missenden Road, Camperdown, Sydney, NSW, 2050, Australia
| | - C Dufouil
- INSERM U708, Paris, France
- UPMC University of Paris, Paris, France
| | - A Pillai
- The George Institute for International Health, The University of Sydney, PO Box M201, Missenden Road, Camperdown, Sydney, NSW, 2050, Australia
| | - M Cooper
- Baker IDI Heart Research Institute, Melbourne, VIC, Australia
| | - D E Grobbee
- Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht, the Netherlands
| | - M Hackett
- The George Institute for International Health, The University of Sydney, PO Box M201, Missenden Road, Camperdown, Sydney, NSW, 2050, Australia
| | - P Hamet
- Centre Hospitalier de l'Université de Montreal and Université de Montreal, Montreal, QC, Canada
| | - S R Heller
- University of Sheffield and Sheffield Teaching Hospitals National Health Service Foundation Trust, Sheffield, UK
| | - L Lisheng
- Chinese Hypertension League Institute, Beijing, China
| | - S MacMahon
- The George Institute for International Health, The University of Sydney, PO Box M201, Missenden Road, Camperdown, Sydney, NSW, 2050, Australia
| | - G Mancia
- University of Milan-Bicocca and San Gerardo Hospital, Milan, Italy
| | - B Neal
- The George Institute for International Health, The University of Sydney, PO Box M201, Missenden Road, Camperdown, Sydney, NSW, 2050, Australia
| | - C Y Pan
- Chinese People's Liberation Army General Hospital, Beijing, China
| | - A Patel
- The George Institute for International Health, The University of Sydney, PO Box M201, Missenden Road, Camperdown, Sydney, NSW, 2050, Australia
| | - N Poulter
- Imperial College and St Mary's Hospital, London, UK
| | - F Travert
- UPMC University of Paris, Paris, France
| | - M Woodward
- The George Institute for International Health, The University of Sydney, PO Box M201, Missenden Road, Camperdown, Sydney, NSW, 2050, Australia
- Mount Sinai School of Medicine, New York, NY, USA
| | | |
Collapse
|
28
|
Akalin S, Berntorp K, Ceriello A, Das AK, Kilpatrick ES, Koblik T, Munichoodappa CS, Pan CY, Rosenthall W, Shestakova M, Wolnik B, Woo V, Yang WY, Yilmaz MT. Intensive glucose therapy and clinical implications of recent data: a consensus statement from the Global Task Force on Glycaemic Control. Int J Clin Pract 2009; 63:1421-5. [PMID: 19769698 DOI: 10.1111/j.1742-1241.2009.02165.x] [Citation(s) in RCA: 47] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
Abstract
BACKGROUND There is compelling evidence showing that achieving good glycaemic control reduces the risk of microvascular complications in people with type 1 and type 2 diabetes. Likewise, there is clear evidence to show that achieving good glycaemic control reduces the risk of macrovascular complications in type 1 diabetes. The UKPDS 10-year follow up suggests that good glycaemic control also reduces the risk of macrovascular complications in type 2 diabetes. Despite this, recent results from ACCORD, ADVANCE and VADT present conflicting results and data from the ACCORD trial appear to suggest that very low HbA(1c) targets (<6.0%) may, in fact, be dangerous in certain patient populations. AIM To review recent results from ACCORD, ADVANCE and VADT and provide clear guidance on the clinical significance of the new data and their implications for the practising physician treating patients with type 2 diabetes. METHODS A Pubmed search was used to identify major randomised clinical trials examining the association between glycaemic control and diabetes-associated complications. The data was reviewed and discussed by the GTF through a consensus meeting. The recommendations for clinical practice in this statement are the conclusions of these analyses and discussions. RESULTS Evidence from ACCORD, ADVANCE, VADT and UKPDS suggests that certain patient populations, such as those with moderate diabetes duration and/or no pre-existing CVD, may benefit from intensive blood glucose control. These trials highlight the benefit of a multifactorial treatment approach to diabetes. However, ACCORD results indicate that aggressive HbA(1c) targets (<6.0%) may not be beneficial in patients with existing CVD and a longer duration of diabetes. CONCLUSIONS Glycaemic control remains a very important component of treatment for type 2 diabetes and contrasting results from the ACCORD, ADVANCE and VADT should not discourage physicians from controlling blood glucose levels.
Collapse
Affiliation(s)
- S Akalin
- Department of Internal Medicine: Endocrinology and Metabolism, Marmara University, Istanbul, Turkey
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
29
|
Pan CY, Ho LT, Soegondo S, Prodjosudjadi W, Suwanwalaikorn S, Lim SC, Chan TM, Chow KWS, Thoenes M, Choi DS. Prevalence of albuminuria and cardiovascular risk profile in a referred cohort of patients with type 2 diabetes: an Asian perspective. Diabetes Technol Ther 2008; 10:397-403. [PMID: 18715217 DOI: 10.1089/dia.2007.0296] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Abstract
BACKGROUND Microalbuminuria (MA) is a risk marker for diabetic nephropathy and cardiovascular (CV) disease (CVD) in patients with diabetes. This study aimed to describe the prevalence of albuminuria, CV risk factors, and treatments for renal and CV protection in an Asian population with type 2 diabetes. METHODS This cross-sectional study conducted in eight Asian countries enrolled normotensive/hypertensive adults with type 2 diabetes without known proteinuria and/or non-diabetic kidney disease. Exclusion criteria were type 1 diabetes, menstruation, pregnancy, and acute fever. A single random urinary albumin/creatinine test was carried out in all patients. RESULTS Of 8,561 patients, 14% had diabetic retinopathy, and 17% and 21% had history of CV disease and smoking, respectively. Normoalbuminuria was seen in 44%, MA in 44%, and macroalbuminuria in 12%. Target glycosylated hemoglobin (HbA1c) (<7%) was reached in only 37% of 3,834 patients with available values. Diabetes was managed by diet alone in 6%, while others received oral hypoglycemic drugs and/or insulin. In total, 75% did not reach target blood pressure (BP) of <or=130/80 mm Hg. Antihypertensive drugs were prescribed to 52%, with the number of drugs increasing as the level of systolic BP increased. Drugs blocking the renin-angiotensin system were most commonly prescribed, followed by calcium channel blockers. Lipid-lowering drugs and anticoagulant/antiplatelet agents were used in about 30% and 25% of patients, respectively. CONCLUSIONS Asian patients with type 2 diabetes had a high prevalence of MA and reduced kidney function. Furthermore, BP and HbA1c control was only achieved in a minority of patients. Aggressive risk management by administration of reno- and cardioprotective treatments is urgently needed.
Collapse
Affiliation(s)
- C Y Pan
- Chinese PLA General Hospital, Beijing, People's Republic of China.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
30
|
Lan XY, Shu JH, Chen H, Pan CY, Lei CZ, Wang X, Liu SQ, Zhang YB. A PstI polymorphism at 3'UTR of goat POU1F1 gene and its effect on cashmere production. Mol Biol Rep 2008; 36:1371-4. [PMID: 18654839 DOI: 10.1007/s11033-008-9322-4] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/28/2008] [Accepted: 07/14/2008] [Indexed: 11/30/2022]
Abstract
POU1F1 is a positive regulator for prolactin (PRL) whose metabolites may directly or indirectly affect some aspects of the hair growth cycle, therefore, POU1F1 gene is an important candidate gene for cashmere traits selection through marker-assisted selection (MAS). Hence, in this study, the PCR-RFLP method was applied to detect a T>C transition determining a PstI polymorphism at the 3'UTR of POU1F1 locus and evaluate its associations with cashmere traits in 847 Inner Mongolia White Cashmere goats. In the analyzed population, the allelic frequencies for the T and C alleles are 0.959 and 0.041, respectively and the genotypic frequencies are in Hardy-Weinberg equilibrium (P > 0.05). Moreover, significant statistical relationships between the PstI polymorphism of POU1F1 gene and goat cashmere yields were found (*P < 0.05). When compared with TC genotype, TT genotype was associated with superior cashmere yields in 2, 4, and 5 years old individuals, as well as with average cashmere yield. Hence, TT genotype is suggested to be a molecular marker for senior cashmere yield.
Collapse
Affiliation(s)
- X Y Lan
- College of Animal Science and Technology, Northwest A&F University, Shaanxi Key Laboratory of Molecular Biology for Agriculture, No. 22, Xinong Road, Yangling, Shaanxi, 712100, China
| | | | | | | | | | | | | | | |
Collapse
|
31
|
Thai AC, Mohan V, Khalid BAK, Cockram CS, Pan CY, Zimmet P, Yeo JP. Islet autoimmunity status in Asians with young-onset diabetes (12-40 years): association with clinical characteristics, beta cell function and cardio-metabolic risk factors. Diabetes Res Clin Pract 2008; 80:224-30. [PMID: 18207602 DOI: 10.1016/j.diabres.2007.12.003] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/21/2007] [Accepted: 12/04/2007] [Indexed: 10/22/2022]
Abstract
In this paper, the islet autoimmunity status and relation to clinical characteristics, beta cell function and cardio-metabolic risk factors in young-onset Asian diabetic patients are evaluated at baseline. The study population consisted of 912 patients (from China, India, Malaysia and Singapore) with age 12-40 years and diabetes duration <12 months. Autoantibodies to glutamic acid decarboxylase (GADA) and tyrosine phosphatase (IA-2A), beta cell function and cardio-metabolic risk parameters were assessed. Among our young patient cohort, 105 (11.5%) patients were GADA and/or IA-2A positives (Ab +ve). Ab +ve patients were younger, leaner, had more severe hyperglycaemia and lower beta cell function. The frequency of metabolic syndrome was significantly lower in Ab +ve patients (27%) compared to Ab -ve patients (54%). However, a substantial proportion of patients in both groups of patients had atherogenic dyslipidaemia, hypertension and albuminuria (micro or macro). In our study cohort, only one in 10 Asian youth with new-onset diabetes had evidence of islet autoimmunity. At least 60% of Ab +ve and 50% of Ab -ve patients demonstrated classical features of type 1 and type 2 diabetes respectively. Regardless of autoimmunity status, the cardio-metabolic risk factors, in particular atherogenic dyslipidaemia, hypertension and albuminuria were common in our patients with young-onset diabetes.
Collapse
Affiliation(s)
- A C Thai
- Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, 5 Lower Kent Ridge Road, 119074 Singapore, Singapore
| | | | | | | | | | | | | |
Collapse
|
32
|
Patel A, MacMahon S, Chalmers J, Neal B, Woodward M, Billot L, Harrap S, Poulter N, Marre M, Cooper M, Glasziou P, Grobbee DE, Hamet P, Heller S, Liu LS, Mancia G, Mogensen CE, Pan CY, Rodgers A, Williams B. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet 2007; 370:829-40. [PMID: 17765963 DOI: 10.1016/s0140-6736(07)61303-8] [Citation(s) in RCA: 1380] [Impact Index Per Article: 81.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/06/2023]
Abstract
BACKGROUND Blood pressure is an important determinant of the risks of macrovascular and microvascular complications of type 2 diabetes, and guidelines recommend intensive lowering of blood pressure for diabetic patients with hypertension. We assessed the effects of the routine administration of an angiotensin converting enzyme (ACE) inhibitor-diuretic combination on serious vascular events in patients with diabetes, irrespective of initial blood pressure levels or the use of other blood pressure lowering drugs. METHODS The trial was done by 215 collaborating centres in 20 countries. After a 6-week active run-in period, 11 140 patients with type 2 diabetes were randomised to treatment with a fixed combination of perindopril and indapamide or matching placebo, in addition to current therapy. The primary endpoints were composites of major macrovascular and microvascular events, defined as death from cardiovascular disease, non-fatal stroke or non-fatal myocardial infarction, and new or worsening renal or diabetic eye disease, and analysis was by intention-to-treat. The macrovascular and microvascular composites were analysed jointly and separately. This trial is registered with ClinicalTrials.gov, number NCT00145925. FINDINGS After a mean of 4.3 years of follow-up, 73% of those assigned active treatment and 74% of those assigned control remained on randomised treatment. Compared with patients assigned placebo, those assigned active therapy had a mean reduction in systolic blood pressure of 5.6 mm Hg and diastolic blood pressure of 2.2 mm Hg. The relative risk of a major macrovascular or microvascular event was reduced by 9% (861 [15.5%] active vs 938 [16.8%] placebo; hazard ratio 0.91, 95% CI 0.83-1.00, p=0.04). The separate reductions in macrovascular and microvascular events were similar but were not independently significant (macrovascular 0.92; 0.81-1.04, p=0.16; microvascular 0.91; 0.80-1.04, p=0.16). The relative risk of death from cardiovascular disease was reduced by 18% (211 [3.8%] active vs 257 [4.6%] placebo; 0.82, 0.68-0.98, p=0.03) and death from any cause was reduced by 14% (408 [7.3%] active vs 471 [8.5%] placebo; 0.86, 0.75-0.98, p=0.03). There was no evidence that the effects of the study treatment differed by initial blood pressure level or concomitant use of other treatments at baseline. INTERPRETATION Routine administration of a fixed combination of perindopril and indapamide to patients with type 2 diabetes was well tolerated and reduced the risks of major vascular events, including death. Although the confidence limits were wide, the results suggest that over 5 years, one death due to any cause would be averted among every 79 patients assigned active therapy.
Collapse
Affiliation(s)
- Anushka Patel
- Cardiovascular Division, The George Institute for International Health, University of Sydney, PO Box M201, Missenden Road, Sydney, NSW 2050, Australia.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
33
|
Abstract
BACKGROUND Encephalitis is a complex, debilitating, and sometimes fatal neurologic condition to which children are especially prone. Mycoplasma pneumoniae, a common respiratory pathogen, has been implicated as an etiology of encephalitis. Evidence for recent or acute M. pneumoniae infection has been demonstrated in limited studies of both pediatric and adult patients with encephalitis. PATIENTS AND METHODS Unexplained encephalitis cases are referred to the California Encephalitis Project for diagnostic testing. Serum, cerebrospinal fluid, and respiratory specimens are tested by polymerase chain reaction and serology methods for the presence of multiple pathogens, including M. pneumoniae. M. pneumonia-associated cases of encephalitis were compared with other bacterial agents, herpes simplex virus 1, and enterovirus. RESULTS Of 1988 patients referred to the California Encephalitis Project, evidence of acute M. pneumoniae infection was found in 111 patients, of which 84 (76%) were pediatric patients. Eighty percent of the 84 patients were positive for M. pneumoniae by serology alone. Cerebrospinal fluid polymerase chain reaction for M. pneumoniae was rarely positive (2%). Patients with M. pneumoniae-associated pediatric encephalitis were a median of 11 years old, progressed rapidly (median: 2 days from onset to hospitalization), and were often in the ICU (55%). Symptoms included fever (70%), lethargy (68%), and altered consciousness (58%). Gastrointestinal (45%) and respiratory (44%) symptoms were less common. Compared with patients with other bacterial as well as viral agents, patients with M. pneumoniae-associated encephalitis had fewer seizures and less-severe hospital courses. CONCLUSIONS M. pneumoniae is the most common agent implicated in the California Encephalitis Project. Patients with M. pneumoniae-associated encephalitis are predominantly pediatric, and their presentations are clinically similar to enterovirus encephalitis, although they frequently require intensive care with prolonged hospitalizations. Given that M. pneumoniae infection is found more than any other pathogen, increased emphasis should be placed on elucidating the role and mechanism of M. pneumoniae in encephalitis.
Collapse
Affiliation(s)
- Laura J Christie
- Viral and Rickettsial Disease Laboratory, California Department of Health Services, 850 Marina Bay Pkwy, Richmond, CA 94804, USA.
| | | | | | | | | | | | | | | |
Collapse
|
34
|
Louie JK, Schnurr DP, Pan CY, Kiang D, Carter C, Tougaw S, Ventura J, Norman A, Belmusto V, Rosenberg J, Trochet G. A summer outbreak of human metapneumovirus infection in a long-term-care facility. J Infect Dis 2007; 196:705-8. [PMID: 17674312 DOI: 10.1086/519846] [Citation(s) in RCA: 59] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2006] [Accepted: 03/12/2007] [Indexed: 11/03/2022] Open
Abstract
Human metapneumovirus (hMPV), a recently discovered paramyxovirus, is thought to be primarily a winter-spring pathogen affecting young children with a clinical presentation similar to that of respiratory syncytial virus. In June-July 2006, a respiratory outbreak in a long-term-care facility was reported to the local health department and investigated. Surveillance identified 26 residents and 13 staff with acute respiratory illness; 8 residents (31%) developed radiographically confirmed pneumonia, and 2 (5%) were hospitalized. Five of 14 respiratory specimens were positive by polymerase chain reaction assay for hMPV; sequencing identified genotype A. In institutionalized elderly persons, hMPV may be an important cause of respiratory outbreaks year-round.
Collapse
Affiliation(s)
- Janice K Louie
- California Department of Health Services, Richmond, CA 94804, USA.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
35
|
Liang SX, Zhu XD, Lu HJ, Pan CY, Li FX, Huang QF, Wang AY, Chen L, Fu XL, Jiang GL. Hypofractionated three-dimensional conformal radiation therapy for primary liver carcinoma. Cancer 2005; 103:2181-8. [PMID: 15812834 DOI: 10.1002/cncr.21012] [Citation(s) in RCA: 72] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Abstract
BACKGROUND The purpose of the current study was to evaluate the tolerance and efficacy of hypofractionated three-dimensional conformal radiotherapy (3DCRT) with or without transarterial chemoembolization (TACE) for technically unresectable or medically inoperable primary liver carcinoma (PLC). METHODS Between April 1999 and August 2003, 128 patients with a clinical diagnosis of PLC received hypofractionated 3DCRT at Cancer Hospital, Guangxi Medical University. Both hypofractionated 3DCRT and TACE were used to treat 48 of these 128 patients. Liver cirrhosis of Child-Pugh Grade A was found in 108 patients, and Grade B was found in 20 patients. The mean gross tumor volume (GTV) was 459 +/- 430 cm3. A mean total irradiation dose of 53.6 +/- 6.6 Gy was delivered at an average fraction of 4.88 +/- 0.47 Gy, 3 times a week using 8-MV photons. RESULTS The median follow-up time after 3DCRT was 12 months (range, 2-56 mos.). The immediate response rate was 55%. The overall survival rates at 1, 2, and 3 years were 65%, 43%, and 33%, respectively, with a median survival of 20 months (range, 7-31 mos.). Radiation Therapy Oncology Group (RTOG) Grade 2 acute gastrointestinal complications developed in 8 patients, whereas 4 patients developed Grade 3 late gastrointestinal complications. Radiation-induced liver disease (RILD) developed in 19 (15%) patients, of which 12 had Child-Pugh Grade B liver cirrhosis, and 7 had Grade A. GTV and associated liver cirrhosis were identified by Cox regression analysis as independent predictors for survival (P = 0.044 and 0.015). CONCLUSIONS Hypofractionated 3DCRT is effective in carefully selected patients with PLC. Gastrointestinal complications and RILD were the most distinct complications.
Collapse
Affiliation(s)
- Shi-Xiong Liang
- Department of Radiation Oncology, Cancer Hospital, Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, China
| | | | | | | | | | | | | | | | | | | |
Collapse
|
36
|
Abstract
AIMS To investigate the difference of urinary albumin excretion rate (UAER) and microalbuminuria (MAU) in various glucose tolerance subjects, especially between isolated-impaired glucose tolerance subjects and isolated-impaired fasting glycaemia subjects. METHODS A total of 2934 subjects were divided into five groups with various glucose tolerances, based on a 75-g oral glucose tolerance test. Microalbuminuria was defined when urinary albumin excretion rate was between 20 and 200 microg/min. RESULTS (i) The UAER in the newly diagnosed Type 2 diabetes mellitus group, impaired glucose tolerance/impaired fasting glycaemia group and isolated-impaired glucose tolerance group were all higher than that in the isolated-impaired fasting glycaemia group and normal glucose tolerance group, but it was comparable between isolated-impaired fasting glycemia group and normal glucose tolerance group. The prevalence of MAU and the odds ratio for MAU with adjustment for age and sex in various glucose tolerance groups showed the same trend as the UAER. (ii) After adjusting for age and sex, there is a significant association between logUAER and independent risk factors (partial correlation coefficients: r = 0.26 for 2-h post-challenge blood glucose, r = 0.26 for systolic blood pressure, r = 0.27 for diastolic blood pressure, r = 0.27 for body mass index and r = -0.13 for high density lipoprotein-cholesterol, all P < 0.001). The risks for MAU were 2-h post-challenge blood glucose, body mass index and diastolic blood pressure, while high density lipoprotein-cholesterol was protective. CONCLUSIONS The urinary albumin excretion rate and prevalence of microalbuminuria were higher in isolated-impaired glucose tolerance subjects than those in isolated-impaired fasting glycaemia subjects. At early abnormal glucose tolerance stage, the increasing post-challenge glycaemia might be a more important risk factor for urinary albumin excretion rate and microalbuminuria than increasing fasting glycaemia.
Collapse
Affiliation(s)
- X L Wang
- Department of Endocrinology, Chinese PLA General Hospital, Beijing, China
| | | | | | | | | |
Collapse
|
37
|
Wu AYT, Kong NCT, de Leon FA, Pan CY, Tai TY, Yeung VTF, Yoo SJ, Rouillon A, Weir MR. An alarmingly high prevalence of diabetic nephropathy in Asian type 2 diabetic patients: the MicroAlbuminuria Prevalence (MAP) Study. Diabetologia 2005; 48:17-26. [PMID: 15616801 DOI: 10.1007/s00125-004-1599-9] [Citation(s) in RCA: 149] [Impact Index Per Article: 7.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/06/2004] [Accepted: 10/22/2004] [Indexed: 11/28/2022]
Abstract
AIM/HYPOTHESIS Microalbuminuria represents the earliest clinical evidence of diabetic nephropathy and is a marker of increased cardiovascular morbidity and mortality. Its early detection allows the implementation of individualised and aggressive intervention programmes to reduce cardiovascular risk factors. There is limited information on the prevalence of microalbuminuria among hypertensive type 2 diabetic patients in Asia. METHODS This cross-sectional epidemiological study aimed to assess the prevalence of microalbuminuria and macroalbuminuria among consecutively screened hypertensive type 2 diabetic adult patients in 103 centres in 10 Asian countries or regions. Predictive factors for microalbuminuria and macroalbuminuria were characterised using a stepwise logistic regression model. RESULTS A total of 6,801 patients were enrolled and 5,549 patients constituted the per-protocol population (patients with bacteriuria and haematuria were excluded). The prevalence of microalbuminuria was 39.8% (39.2-40.5; 95% CI) and the prevalence of macroalbuminuria was 18.8% (18.2-19.3; 95% CI). Only 11.6% of the patients had systolic and diastolic blood pressure below the 130/80 mm Hg target. In the multivariate analyses, the predictive factors for the presence of microalbuminuria were age, BMI, systolic blood pressure and ethnic origin. The highlighted predictive factors for the presence of macroalbuminuria were age, sex, ethnic origin, BMI, duration of diabetes, presence of diabetic complications, intake of diuretics, intake of calcium channel blockers, diastolic and systolic blood pressure. CONCLUSIONS/INTERPRETATION The high prevalence (58.6%) of micro or macroalbuminuria observed in these patients is alarming and indicates an impending pandemic of diabetic cardiovascular and renal diseases in Asia with its potential economic consequences.
Collapse
Affiliation(s)
- A Y T Wu
- Wu Nephrology and Medical Clinic, Mount Elizabeth Medical Center, 3 Mount Elizabeth, 2258510, Singapore.
| | | | | | | | | | | | | | | | | |
Collapse
|
38
|
Pan CY, So WY, Khalid BAK, Mohan V, Thai AC, Zimmet P, Cockram CS, Jorgensen LN, Yeo JP. Metabolic, immunological and clinical characteristics in newly diagnosed Asian diabetes patients aged 12-40 years. Diabet Med 2004; 21:1007-13. [PMID: 15317606 DOI: 10.1111/j.1464-5491.2004.01287.x] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
Abstract
AIM To describe the clinical, biochemical and immunological characteristics of young-onset diabetes in Asia. METHODS Clinical, biochemical and immunological variables were assessed in 919 newly diagnosed (duration less than 12 months) young onset Asian diabetic patients aged between 12 and 40 years. The subjects constituted 57% Chinese, 29% Indians and 14% Malays, recruited from diabetes centres in China, Hong Kong, India, Malaysia and Singapore. RESULTS The mean age (+/- sd) was 31.6 +/- 7.2 years, with the majority (66%) in the 31-40 years age group. Mean body mass index (BMI) (+/- sd) was 25.3 +/- 5.0 kg/m2 with 47% exceeding the suggested Asian cut-off point for obesity (BMI > or = 25). Ethnic difference in clinical characteristics included BMI, blood pressure, mode of treatment and degree of insulin resistance. Most patients had a clinical presentation of Type 2 diabetes. About 10% had a classical combination of ketotic presentation, presence of autoimmune-markers and documented insulin deficiency indicative of Type 1 diabetes. Forty-eight percent were receiving oral hypoglycaemic agents (OHAs) while 31% were on diet only, 18% were receiving insulin and 2% were on a combination of insulin and OHA. CONCLUSION Young onset diabetes patients in Asia represent a heterogeneous group in terms of their clinical and biochemical characteristics and classical Type 1 diabetes is relatively uncommon. The 5-year follow up study will determine the progress of these patients and help to clarify the natural history.
Collapse
Affiliation(s)
- C Y Pan
- Chinese PLA General Hospital, Beijing, China.
| | | | | | | | | | | | | | | | | |
Collapse
|
39
|
Nitiyanant W, Tandhanand S, Mahtab H, Zhu XX, Pan CY, Raheja BS, Sathe SR, Soegondo S, Soewondo P, Kim YS, Embong M, Lantion-Ang L, Lim-Abraham MA, Lee WWR, Wijesuriya M, Tai TY, Chuang LM, Le HL, Cockram C, Jorgensen LN, Yeo JP. The Diabcare-Asia 1998 study--outcomes on control and complications in type 1 and type 2 diabetic patients. Curr Med Res Opin 2002; 18:317-27. [PMID: 12240795 DOI: 10.1185/030079902125000822] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
UNLABELLED The aim of this study was to describe the glycaemic and metabolic control and diabetes-related complications in type 1 and type 2 Asian patients. METHODS Data of diabetes patients from 230 diabetes centres in 12 Asian regions were collected on a retrospective-prospective basis through review of medical records, interview and laboratory assessments. Analysis of glycated haemoglobin (HbA1c) was carried out in central laboratories appointed by Bio-Rad. The data collection case record forms were scanned electronically. RESULTS 22177 patients with valid data made up the analysis population. Among patents with type 1 and type 2 diabetes, there was a higher proportion of women than men (53% vs. 47% for type 1 patients and 56% vs. 44% for type 2 diabetes). Hypertension (61%) and overweight (40% with BMI > or = 25 kg/m2 were common in type 2 patients. Dyslipidaemia was also present in at least half of both types of patients. Control of glycaemia (mean HbA,1c and fasting blood glucose [FBG]) was poor in type 1 (9.9 +/- 2.5%; 10.2 +/- 5.2 mmol/l) and type 2 patients (8.5 +/- 2.0%; 8.9 +/- 3.4 mmol/l). Glycaemia in the majority of both types of patients fell short of those stipulated by various guidelines. In type 2 patients, glycaemia deteriorated (HbA1c > 7.5%, FBG > or = 7.0 mmol/l) with duration of diabetes > 7 years. Both types of diabetes appear to share a similar high prevalence of complications of cataract, retinopathy and neuropathy, although the prevalence of cataract (27%) and neuropathy (35%) was higher in type 2 diabetes. Screening for microalbuminuria was not common. CONCLUSIONS The Inadequate metabolic and hypertension control, especially in type 2 patients, needs to be addressed.
Collapse
Affiliation(s)
- W Nitiyanant
- Department of Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkoknoi, Bangkok, Thailand.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
40
|
Sreenan SK, Zhou YP, Otani K, Hansen PA, Currie KP, Pan CY, Lee JP, Ostrega DM, Pugh W, Horikawa Y, Cox NJ, Hanis CL, Burant CF, Fox AP, Bell GI, Polonsky KS. Calpains play a role in insulin secretion and action. Diabetes 2001; 50:2013-20. [PMID: 11522666 DOI: 10.2337/diabetes.50.9.2013] [Citation(s) in RCA: 113] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
Studies of the genetic basis of type 2 diabetes suggest that variation in the calpain-10 gene affects susceptibility to this common disorder, raising the possibility that calpain-sensitive pathways may play a role in regulating insulin secretion and/or action. Calpains are ubiquitously expressed cysteine proteases that are thought to regulate a variety of normal cellular functions. Here, we report that short-term (4-h) exposure to the cell-permeable calpain inhibitors calpain inhibitor II and E-64-d increases the insulin secretory response to glucose in mouse pancreatic islets. This dose-dependent effect is observed at glucose concentrations above 8 mmol/l. This effect was also seen with other calpain inhibitors with different mechanisms of action but not with cathepsin inhibitors or other protease inhibitors. Enhancement of insulin secretion with short-term exposure to calpain inhibitors is not mediated by increased responses in intracellular Ca2+ or increased glucose metabolism in islets but by accelerated exocytosis of insulin granules. In muscle strips and adipocytes, exposure to both calpain inhibitor II and E-64-d reduced insulin-mediated glucose transport. Incorporation of glucose into glycogen in muscle also was reduced. These results are consistent with a role for calpains in the regulation of insulin secretion and insulin action.
Collapse
Affiliation(s)
- S K Sreenan
- Deppartment of Medicine, the University of Chicago, Chicago, Illinois, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
41
|
Affiliation(s)
- J D Marks
- Department of Pediatrics, University of Chicago, Chicago, Illinois 60637, USA.
| | | | | | | | | |
Collapse
|
42
|
Li CH, Luo Y, Li XJ, Cui X, Xue YL, Pan CY. [Study of the growth and secretion of microencapsulated pancreatic B cell line in vitro]. Zhongguo Ying Yong Sheng Li Xue Za Zhi 2001; 17:93-96. [PMID: 21171456] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
Abstract
AIM To study the growth and secretion of pancreatic B cell line BTC6-F7 in the alginate polylysine-alginate (APA) microcapsules and explore the possibility of utilizing it as bioartificial islets. METHODS Microencapsulated BTC6-F7 cells prepared with electric droplet generator were cultured in vitro, and the growth and insulin secretion of them were measured periodically. RESULTS Over the 90-day observation period, BTC6-F7 cells were able to grow and survive as cell clusters in the microcapsules and finally fulfill the capsules. But the microcapsules remained well after the long-time culture. The average total cell number per capsule were increasing with time, but the cell viability was decreasing. The changes of insulin secretion and average live cell number per capsule were in a same manner: for the first two weeks they increased rapidly and then maintained in a relatively constant levels for the rest time. CONCLUSION The microencapsulated pancreatic B cells prepared by us could survive, grow and secretion for a long time. This has made a basis for further development of bioartificial islets, and also can be used to study the mechanism and therapy of diabetes mellitus.
Collapse
Affiliation(s)
- C H Li
- Institute of basic medical sciences, General Hospital of PLA, Bejing, 100853
| | | | | | | | | | | |
Collapse
|
43
|
Abstract
In this study, the relationship between intracellular calcium stores and depolarization-evoked stimulation was examined in bovine chromaffin cells, using changes in membrane capacitance to monitor both exocytosis and endocytosis. Cells were voltage-clamped using the perforated whole-cell patch configuration to minimize alterations in intracellular constituents. Control cells exhibited reproducible secretory responses each time the cell was stimulated. However, the same stimulation protocol elicited progressively smaller secretory responses in cells where their intracellular calcium store was emptied by thapsigargin. Transient elevation of the intracellular calcium concentration with a brief histamine treatment enhanced subsequent secretory responses in control but not in thapsigargin-treated cells. A series of depolarizations to -20 mV, which allowed small amounts of Ca(2+) influx but which by itself did not trigger catecholamine secretion, enhanced subsequent exocytosis in both control and thapsigargin-treated cells. Caffeine-pretreated cells exhibited a rundown in the secretory response that was similar to that produced by thapsigargin. These results suggest that brief elevations of [Ca(2+)](i) could enhance subsequent secretory responses. In addition, the data suggest that intracellular calcium stores are vital for the maintenance of exocytosis during repetitive stimulation.
Collapse
Affiliation(s)
- C Y Pan
- Department of Neurobiology, Pharmacology, and Physiology, University of Chicago, IL 60637, USA
| | | |
Collapse
|
44
|
Buchacz K, Pan CY, van der Straten A, Hanson CV, Padian N. HIV viral load and viral cultures in sexually active heterosexual men. J Acquir Immune Defic Syndr 2000; 23:98-9. [PMID: 10708063 DOI: 10.1097/00126334-200001010-00015] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
45
|
Abstract
AIMS To evaluate the effect of metformin on glucose metabolism, insulin sensitivity and rate of conversion diabetes in people with impaired glucose tolerance (IGT). METHODS Seventy subjects with IGT were randomized under double-blind conditions to receive either placebo (n = 37) or metformin (n = 33) at a dosage of 250 mg three times daily for a duration of 12 months. Glycaemic control, plasma insulin and other biochemical indexes were assessed before and after 3, 6 and 12 months. RESULT At 12 months the conversion rate to diabetes was 16.2% in the placebo group compared to 3.0% for the metformin group (P = 0.011). Of subjects treated with metformin for 12 months, 84.9% became normoglycaemic compared to 51.4% of those receiving the placebo. Significant improvements in fasting glucose, glucose tolerance and insulin sensitivity were found at 12 months and at intermediate clinic assessments. CONCLUSIONS Metformin can improve glucose metabolism in IGT patients and may be a treatment option in their management of IGT subjects.
Collapse
Affiliation(s)
- C L Li
- Department of Endocrinology, Chinese PLA General Hospital, Beijing.
| | | | | | | | | | | | | | | | | |
Collapse
|
46
|
Abstract
To identify the Na+/Ca2+ exchanger expressed in bovine chromaffin cells, the ncx gene was cloned from a bovine chromaffin cell cDNA library. Five partial clones were obtained and their nucleotide sequences showed that there were at least three isoforms containing different intracellular loops. The 3'-untranslated region was the same in all the clones. To examine the Na+/Ca2+ exchange activity of the clones, full-length ncx1 genes were constructed by replacing the corresponding region of bovine cardiac ncx1 clone p17 with the different regions from two bovine chromaffin cell clones; these were designated p17c and p17h. p17h, but not p17c, showed Na+/Ca2+ exchange activity when expressed in Chinese hamster ovary cells and Xenopus oocytes. The expressed exchange activity of p17 was inhibited by 8-bromoadenosine 3':5'-cyclic monophosphate (8-Br-cAMP) but was not affected by PMA. However, the activity of p17h was inhibited by PMA but enhanced by 8-Br-cAMP. The agents that changed the activity of protein kinase C and cAMP-dependent protein kinase modulated the endogenous Na+/Ca2+ exchange current of chromaffin cells in a manner similar to that of p17h. Our results suggest that the p17h clone is the major isoform of the exchanger in chromaffin cells and is similar to the major ncx1 isoform in kidney. The exchange activity could be regulated by phosphorylation, and the variable region in the intracellular loop is important for the different effects of phosphorylation on the different isoforms.
Collapse
Affiliation(s)
- C Y Pan
- Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan, Republic of China
| | | | | |
Collapse
|
47
|
Wang L, Pan CY, Hu W. [Association between ACE gene polymorphism and therapeutic responsiveness of ACEI in diabetic nephropathy]. Zhonghua Yi Xue Za Zhi 1998; 78:372-4. [PMID: 10923445] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/17/2023]
Abstract
OBJECTIVE [corrected] To clarify the association between ACE gene polymorphism and therapeutic responsiveness of ACEI in diabetic nephropathy. METHOD With the polymerase chain reaction technique, the angiotensin converting enzyme (ACE) gene insertion/deletion (I/D) polymorphism was studied in 31 NIDDM patients, 58 NIDDM patients with nephropathy, and 50 normal controls. RESULTS There was no significant difference in the frequency of ACE genotypes among those NIDDM patients, NIDDM patients with nephropathy and nomal controls. Among 40 patients of DN group treated with ACE inhibitor(ACE-I), there was significant difference in genotype distribution between 19 efficacious cases and 21 nonefficacious cases: 8/2/9 vs 1/3/17 had DD/DI/II genotypes responsively (P < 0.01), DD genotype was best and II genotype was worst in therapeutic efficacy of ACE-I in NIDDM patients with nephropathy. CONCLUSION The examination of ACE gene polymorphism is helpful for the diagnosis of the therapeutic efficacy of ACE-I in NIDDM with nephropathy.
Collapse
Affiliation(s)
- L Wang
- Department of Endocrinology, Xuanwu Hospital, Capital Medical University, Beijing
| | | | | |
Collapse
|
48
|
Abstract
The role of the Na+/Ca2+ exchanger and intracellular nonmitochondrial Ca2+ pool in the regulation of cytosolic free calcium concentration ([Ca2+]i) during catecholamine secretion was investigated. Catecholamine secretion and [Ca2+]i were simultaneously monitored in a single chromaffin cell. After high-K+ stimulation, control cells and cells in which the Na+/Ca2+ exchange activity was inhibited showed similar rates of [Ca2+]i elevation. However, the recovery of [Ca2+]i to resting levels was slower in the inhibited cells. Inhibition of the exchanger increased the total catecholamine secretion by prolonging the secretion. Inhibition of the Ca2+ pump of the intracellular Ca2+ pool with thapsigargin caused a significant delay in the recovery of [Ca2+]i and greatly enhanced the secretory events. These data suggest that both the Na+/Ca2+ exchanger and the thapsigargin-sensitive Ca2+ pool are important in the regulation of [Ca2+]i and, by modulating the time course of secretion, are important in determining the extent of secretion.
Collapse
Affiliation(s)
- C Y Pan
- Institute of Biomedical Sciences, Academia Sinica, and Department of Biochemistry, National Yang-Ming University, Taipei, Taiwan, Republic of China
| | | |
Collapse
|
49
|
Pan CY, Lu JM, Tian H, Kong XT, Lu XP, Yao C, Jiang CE, Deng XX, Wang SY, Zhang XL, Wang ZS, Cui L. Study of the prevalence of diabetes mellitus in adults in the Shougang Corporation in Beijing. Diabet Med 1996; 13:663-8. [PMID: 8840102 DOI: 10.1002/(sici)1096-9136(199607)13:7<663::aid-dia130>3.0.co;2-g] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Abstract
The aim was to determine the burden of diabetes mellitus (DM) in an urban area of China to aid us in planning preventive measures for those at risk of DM. A survey was conducted among the 29,859 subjects aged between 30 and 64 belonging to 32 units of the Shougang Corporation (a heavy industry enterprise) within the Beijing area. WHO study protocols and diagnostic criteria were used to determine the prevalence of DM and impaired glucose tolerance (IGT). The results showed that the age-adjusted prevalence of DM and impaired glucose tolerance (IGT) was 3.63% and 4.19%, respectively, both increasing with age. Peak prevalence for both occurred in the 60-64 age group. Prevalence showed no difference between the sexes in DM but was higher for females in IGT. Obesity, being overweight, a family history of diabetes mellitus and in women, a history of delivering babies with macrosomia, all correlated closely with the prevalence of DM and IGT. High protein intake was also associated with DM, Smoking had no effect on either DM or IGT. Intellectual workers had a higher incidence of IGT than manual workers. Seventy per cent DM was undiagnosed prior to the survey. This survey, done according to the recommendation of WHO, and including appropriate adjustments, reflects the growing prevalence of DM and IGT in this population. It can be compared with other studies for epidemiological analysis.
Collapse
Affiliation(s)
- C Y Pan
- Chinese PLA General Hospital, Beijing, China
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
50
|
Abstract
To study the role of Rab3A in regulated secretion, recombinant Rab3A protein plus various guanine nucleotides were perfused into bovine adrenal chromaffin cells via a patch pipette, and depolarization-evoked catecholamine secretion from individual cells was measured by amperometry. Rab3A plus GTP, GDP, and GTP gamma S all delayed the occurrence of exocytosis while Rab3A, GTP, or GDP alone had no effect. The delay of evoked-secretion is specific for Rab3A plus guanine nucleotides, since treatments with GTP plus BSA or GDP beta S plus Rab3A had no effect on the appearance of secretion events. Rab3A plus GTP increased the frequency of the exocytosis of smaller packets of catecholamine. These results are consistent with the notion that an excess of Rab3A in the cytoplasm depletes the regulatory proteins responsible for regulating the interconversion between GTP- and GDP-bound forms of Rab3A and that Rab3A is involved in the final steps of regulated exocytosis.
Collapse
Affiliation(s)
- C G Lin
- Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan, ROC
| | | | | |
Collapse
|